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ABSTRACT

The Role oflron in the Mechanism of Asbestos-Induced Apoptosis
in Human Lung and Pleural Target Cells

by

Aleksander Baldys, Doctor of Philosophy
Utah State University , 2004

Major Professor: Ann E . Aust, Ph .D.
Department: Chemistry and Biochemistry

Occupational exposure to asbestos has been associated with increased incidence
of pulmonary interstitial fibrosis, mesothelioma of the pleura, and bronchogenic
carcinoma . Although the mechanism by which asbestos causes cancer remains unknown ,
iron associated with asbestos is thought to play a role in the pathogenic effects of fibers .
The aim of this research was to examine and compare the asbestos-induced
signaling phenomena in relevant human lung and pleural target cells, and to deter mine
the role of iron from asbestos fibers in these events . Exposure of human airway epithelial
(A549) cells, human pleural mesothelial (METSA) cells, and normal human small airway
epithelial (SAEC) cells to asbestos resulted in a significant dephosphorylation and
inactivation of epidermal growth factor receptor (EGFR) . The effects of three types of
asbestos, i.e. crocidolite, amosite and chrysotile, on the EGFR phosphorylation state in
A549 cells appeared to be directly related to the amount of iron mobilized from these
fibers . These results strongly suggest that iron plays an important role in asbestos-
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induced inactivation ofEGFR.
We observed that exposure of A549 and SAEC cells to crocidolite , but not inert
titanium dioxide , led to a significant time- and dose-dependent inactivation of the main
EGFR signaling pathways, including Akt and extracellular signal-regulated kinase 1/2
(ERKI/2) pathways . Crocidolite also initiated apoptosis via pathways involving
activation of p38 mitogen-activated protein kinase (MAPK), caspase -3 and -9, and
cleavage of poly(ADP-ribose) polymerase (PARP) . Prevention of these effects with an
iron chelator or endocytosis inhibitors strongly suggests that iron mobilized fro m fibers
inside the cells initiates the observed events . Inhibition of p38 MAPK with SB203580
prevented inactivation ofEGFR , inactivation ofEGFR-associated

survival path ways , and

initiation of apoptosis. Our results also suggest that p38 MAPK-dependent protein
serine/threonine phosphatase activation plays an important role in the observed
phenomena. Taken together , it appears that iron-dependent p38 MAPK activat ion,
through a serine/threonine phosphatas e-mediated mechanism , regulates asbest os-induced
apoptosis in human lung epithelial cells . We speculat e that apoptosis of human lung
target cells induced by asbestos fibers is a pathologic feature in lung injury and may
account for some of the pulmonary toxicity of the fibers .
(173 pages)

IV

ACKNOWLEDGMENTS

First of all, I would like to express my gratitude to my major advisor, Dr. Ann E.
Aust. I am grateful for the opportunity to work in her laboratory where I broaden my
scientific knowledge, developed leadership skills, and most importantly, became an
independent, better scientist. Thank you for your help and guidance throughout my entire
time at Utah State University.
My sincere appreciation also extends to all of my past and present committee
members, Drs. John W. Peters, Lance C. Seefeldt, Alvan C. Hengge, Jon Y. Takemoto ,
and Joan M. Hevel, for their help and advice. Although at the time of my qualifying
examination I felt a bit embarrassed and confused, unable to come up with good answers
to the posed questions, I am very grateful for these unforgettable moments that helped me
shape myself as a scientist and think more critically. I would like to especially thank Dr.
Jon Y. Takemoto, who has played an important role in my development as a person and a
scientist while at Utah State University .
I have developed many friendships throughout my entire time at Utah State
University, including Ryan Ball, Capt. James Rohrbaugh, David Bienvenue, Binh Luu ,
Paul Benton, Alicja Copik, Monika and Boguslaw Nocek, Robert Igarashi, Miguel
Alejandro Pabon, Sabina and Krzysztof Swierczek, Mekki Bensaci, Sun-Hee Park,
Priyadarshini Pande, Tariq Musleh, Laura and Kris Buelow, to name but a few . .. . Thank
you for the scientific discussions and most of all the good times we have shared over the
years.
I would like to dedicate this dissertation to my mother and wife . To my mother

V

for her love, support, and understanding throughout my years of education . She always
has been and will be the person I look up to. She helped me develop my own confidence
and taught me that one can achieve anything in the world with honesty, hard work,
determination and goodwill . For everything you have done for me I can never thank you
enough!
I owe my biggest thanks to my wife, Jola, who has been my best friend for more
than a decade . Her encouragement, constant support, and good advice helped me cope
with all the frustrations as a person and a graduate student. Thank you for your love,
understanding, and everlasting friendship!
Aleksa nder Baldys

VI

CONTENTS

Page
ABSTRACT .......... ........... ................ ....... ....... ......... ............ ............... ....................... ..... ii
ACKNOWLEDGMENTS ........... ............. ............ ........ ............... ....... ........... ............ ..... iv
LIST OF TABLES .... .................... ..... ........................... ................ ........... ......... ......... . viii
LIST OF FIGURES ................ ............... .................... ...... .......... ...... .................... ...... ..... ix
LIST OF ABBREVIATIONS ................ .......... ............. ................. .................... ........... .. xi
CHAPTER
1.

INTRODUCTION ...... .............. ........ ........... ............... ........ ................... ......... .... 1
REFERENCES ...................... ................. .............. ................................... 4

2.

LITERATURE REVIEW ...... ....................... ........... ..... ....................... ................ 7
RELEVANT ffiJMAN LUNG AND PLEURAL TARGET CELLS ......... 7
ASBESTOS AND IRON .......... .......... ...... ....... .............. ..... ...... ....... ......... 9
UPTAKE OF ASBESTOS FIBERS ............................. .............. ....... ..... 14
EPIDERMAL GROWTH FACTOR RE CEPTOR ................... ..........._.. 15
:MITOGEN-ACTIVATED PROT EIN KINASE AND
PHOSPHATIDYLINOSITOL 3-KINASE -AKT SIGNALING ........ 18
PROTEIN PHOSPHA T ASES ........................ ........ ................ .............. _.21
REDOX SIGNALING ..... ...... .............. ........ ........ ............... ............. ..... 24
APOPTOSIS AND CANCER ..... ............ ....... ...... ............. ............ ......... 28
REFERENCES ....... ........... ....... ...... ........ .......... .......... .......................... . 3 3

3.

ROLE OF IRON IN INACTIVATION OF EGFR AFTER ASBESTOS
TREATMENT OF ffiJMAN LUNG AND PLEURAL TARGET
CELLS .......... ................ .................... ....................................... ..... .......... .......... 55
ABSTRACT ............ ...... .......... ............... ............... ........... .......... ........... 55
INTRODUCTION ...... ............ ......... .......... ......... ....................... ............ 56
MATERIALS AND METHODS ........... ...... ............. ............... .......... ..... 58
RESULTS ...... ................... ......... ........ ....... ...... ..... ............... .......... ......... 63
DISCUSSION ...................... ........... ...... _.......... ........... ..... ..... ............... .. 78
REFERENCES ...................... ............... .............. ............................ ....... 83

VII

4.

CROCIDOLITE IRON INITIATES APOPTOSIS IN HUMAN LUNG
EPITHELIAL CELLS VIAP38 MAPK-MEDIATED PATHWAYS ................. 89
ABSTRACT ....... ................ ....... ......... ............ ....................................... 89
INTRODUCTION .......... ....... .......... ....................... ....................... ........ 90
MATERIALS AND METHODS .......... ............................. .............. ....... 93
RESULTS ................................ ....... ......... ................ .............................. 96
DISCUSSION ...... ..................... .................................. ........ ................. 109
REFERENCES ....... ............................. ....................................... ......... 115

5.

P38 MAPK-DEPENDENT ACTIVATION OF PROTEIN
PHOSPHATASES REGULATES ASBESTOS-INDUCED APOPTOSIS
IN HUMAN LUNG EPITHELIAL CELLS ................ ..... ......... ........ ........... .... 122
ABSTRACT ....... ................................ .................... ............. ...... .......... 122
INTRODUCTION ................. ......... .............. ....................................... 123
MATERIALS AND METHODS ........... ...... ...... ................ ........... ........ 126
RE SUL TS ............... ........ ........ ........ ................................ ................... .. 129
DISCUSSION ....................... .......... ..................... ..... ............... .... ....... 135
REFERENCES .......... ...... .............. ............ ................ ................ .......... 140

6.

SUMMARY ............... ........ ................. ................. .............. ................ ............. 151

CURRICULUM VITAE ................................ ......... ........... ............................ ............. 159

Vlll

LIST OF TABLES

Table
2-1

Page
Chemical Empirical Formula of Asbestos ............. ........ .............. ..................... .. 11

IX

LIST OF FIGURES

Figure

Page

3-1

Effects ofEGF on EGFR Phosphorylation .... ......... ............. ..................... .... ..... 65

3-2

Effects of Three Types of Asbestos Fibers on EGFR Phosphorylation ...... ......... 66

3-3

Effects of Crocidolite on ErbB2/HER2 Phosphorylation. Time Dependence ..... . 67

3-4

Effects ofCrocidolite and TiO 2 on EGFR Activation. Time Dependence .... ....... 69

3-5

Effects of Crocidolite on EGFR Activation . Dose Dependence ........................ . 71

3-6

Effects of Crocidolite on EGFR Degradation ....... ............... .................. ....... ...... 74

3-7

Effects of Cytochalasins, Desferrioxamine B and Phytic Acid on Crocidolite Induced EGFR Inactivation ......... ........ ............ ..................... ................ ...... ..... 75

4-1

Effects of Crocidolite and EGFR Kinase Inhibitor, AG1478, on A.kt and
ERKl/2 Pathways ..... ............. ............ ......... .............. ........ ...................... ..... ...... 97

4-2

Effects of Crocidolite and TiO2 on A.kt and ERK 1/2 Phosphorylation States
in Human Lung Epithelial Cells ...... ................. .............. ............. ..... ............... 100

4-3

Effects of Crocidolite on Total Cellular Phosphothreonine , Phosphoserine
and Phosphotyrosine Levels .......... ........................ .............. ....... ........ ........... . 102

4-4

Effects of Crocidolite on p38 MAPK. Time and Dose Dependences ... ........... 103

4-5

Effects of Crocidolite and TiO 2 on Caspases and Poly(ADP-ribose)
Polymerase States .............. ........... ....... ............ ......... ........... ....... ..... ............... 105

4-6

Effects of p38 MAPK Inhibitor on Crocidolite-Induced Events ..... . .. .. .. . ... . 106

4-7

Effects of Cytochalasins and Desferrioxamine on Crocidolite-Induced
Events .... ... . ...... .. ....... ..... .. .......... .......... .... . ... ... .. . ...... ........ . ........ 108

4-8

Model of Crocidolite-Induced p38 MAPK-Mediated Apoptosis in Human
Lung Epithelial Cells .... ......... ............ ............. ...... .................. ....................... 114

5-1

Effects of Cytochalasins, Desferrioxamine and p38 MAPK Inhibitor on
Crocidolite-Induced Cellular Serine and Tyrosine Dephosphorylation .... ......... 130

X

5-2

Effects of Okadaic Acid and Sodium Orthovanadate on Crocidolite-In duced
Serine and Tyrosine Dephosphorylation ....... ....... ...... ........... ............ ...... ... ...... 133

5-3

Effects of Okadaic Acid and Sodium Orthovanadate on Crocidolite-Induced
Events ............. ....... ..... ..... ........ ..... ...... .... ... ...... ......... ........ ............ .................. . 134

6-1

Model of Crocidolite-lnduced p38 MAPK-Mediated Apoptosis in Human
Lung Epithelial Cells ........ ........ ................... ............ ............ .......... ........ .......... 155

XI

LIST OF ABBREVIATIONS

A549

human airway epithelial cells

ClO

murine alveolar type II epithelial cells

CB

cytochalasin B

CD

cytochalasin D

CFA

coal fly ash

~\Jim

mitochondrial membrane potential changes

DF

desferrioxamine B

DSPases

dual specificity phosphatases

ECL

chemiluminescent detection reagent

EGF

epidermal growth factor

EGFR

epidermal growth factor receptor

ERKI/2

extracellular signal-regulated kinase 1/2

FBS

fetal bovine serum

GSH

glutathione

HER2

human epidermal growth factor receptor 2

H202

hydrogen peroxide

I-1

inhibitor 1

I-2

inhibitor 2

JNK

c-Jun N-terminal kinase

LMW

low-molecular weight

MAPK

mitogen-activated protein kinase

XII

MAPKK

mitogen-activated

protein kinase kinase

MAPKKK

mitogen-activated

protein kinase kinase kinase

MEK

mitogen-activated

protein kinase/extracellular

MET5A

human pleural mesothelial cells

"NO

nitric oxide

NOS

nitric oxide synthase

8-oxodG

8-oxoguanine

02·-

superoxide radical

0A

okadaic acid

-OH

hydroxyl radical

oNoo-

peroxynitrite

PA

phytic acid

PARP

poly(ADP-ribose)

PBS

phosphate-buffered

PDKI

3-phosphoinositide-dependent

PI3K

phosphatidylinositol

PIP3

phosphatidy linositol-3, 4, 5-trisphosphate

PKB

protein kinase B

PPI

serine/threonine phosphatase type I

PP2

serine/threonine phosphatase type 2

PPases

protein phosphatases

PSPases

protein serine/threonine phosphatases

PTB

phosphotyrosine-binding

polymerase
saline
protein kinase I

3-kinase

domain

signal-regulated

kinase

PTPases

protein tyrosine phosphatases

PVDF

polyvinyl difluoride

ROS

reactive oxygen species

RPM

rat pleural mesothelial cells

SAEC

small airway epithelial cells

SAGM

small airway growth medium

SAPK

stress-activated protein kinase

SH

thiol

SH2

Src homology 2

SV40

simian virus 40

TiO2

titanium dioxide

TNF

tumor necrosis factor

TRX

thioredoxin

VA

sodium orthovanadate

Xlll

CHAPTER 1
INTRODUCTION

Asbestos is a naturally occurring mineral that has been used for centuries because
of its unique physical and chemical properties, including durability, tensile strength, and
heat resistance . However, it was recognized to be a human carcinogen in the late 1950s,
which led to a complete cessation of the use of asbestos-containing commercial products .

It has been demonstrated that exposure to asbestos increases the risk of both malignant
(mesothelioma of the pleura and bronchogenic carcinoma of the lungs) (1) and
nonmalignant (asbestosis) diseases (2). Even though it is not clear how asbestos exerts
these effects, the carcinogenicity of asbestos has been related to some of its physic al
properties, such as size and durability of fibers (3). The most carcinogenic forms of
asbestos contain as much as 27% iron by weight (4, 5). It has been proposed that iron
from asbesto s catalyzes the generation of reactive oxygen species (ROS), such as
superoxide radical (0 2 -- ) and hydroxyl radical (-OH) (3, 6). In addition , iron has been
shown to be responsible for 0 2 consumption (7), induction of DNA single -strand breaks
(8), lipid peroxidation (9), and potentially cancer. There is also significant evidenc e
suggesting that iron from other sources besides asbestos may cause human cancer (10,
11).

Another reactive species nitric oxide (NO), produced enzymatically by nitric
oxide synthase (NOS), can react with 0 2 ·- to produce peroxynitrite (ONOO -). Chao et al.
(12) reported that the formation of 8-oxoguanine (8-oxodG), one of the major types of
oxidative DNA damage, increased in asbestos-treated human lung epithelial (A549) cells.
Also, they observed that hydroxylation of DNA could be caused by -OH or ONOO- ,
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implying that both iron and NO may be responsible for the formation of 8-oxodG .
With the exception of mucus cells all airway cells endocytize particles (13). Iron
can be mobilized from asbestos in vitro, in cultured cells and in vivo ( 14-16). This
uncontrolled entry of iron may represent "iron overload" in cells endocytizing the fibers.

It has been suggested that iron mobilization from asbestos into low-molecular weight
(LMW) fraction, non-protein (e.g. citrate or ADP) associated iron in cells might be
responsible for asbestos-dependent cytotoxicity. Although the mechanism by which
asbestos exerts its pathologic effects is not known, at least two plausible mechanisms
should be considered. Asbestos-induced pulmonary toxicity might be initiated by ROS
generated from mobilized iron via Haber-Weiss reactions (3), and possibly by interaction
of asbestos fibers with the plasma membrane through a receptor-like mechanism (17).
Despite a strong body of evidence supporting the involvement of asbestos in lung
diseases and the knowledge we have gained throughout these years with respect to
asbestos-associated carcinogenicity , the light is yet to be shed on the mechanism by
which mineral fibers cause cancer.
The purpose of this dissertation has been to determine whether asbestos-induced
pulmonary effects might , in part, have cell surface origins , and to determine the effects of
asbestos on the control and coordination of the signal transduction pathways in human
lung and pleural cells. More specifically, the objective was to determine whether iron
associated with fibers, as well as the process of fiber endocytosis, played any role in the
proposed hypotheses in relevant human lung and pleural target cells. Chapter 2 is a
review of the literature on the role of iron in the pathological effects of asbestos and the
role of ROS in cellular redox signaling and control. It also serves as an introduction to
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the results presented in this dissertation.
The results presented in Chapter 3 strongly suggest that iron associated with fibers
plays an important role in asbestos-induced inactivation of epidermal growth factor
receptor (EGFR) . This chapter discusses the effects of asbestos fibers on the EGFR
activity in relevant human lung and pleural target cells, i.e. epithelial (A549 and small
airway epithelial (SAEC) cells) and mesothelial (human pleural mesothelial (MET5A)
cells) cells. Our results indicated that in contrast to rodent cells, treatment of human lung
epithelial and pleural mesothelial cells with asbestos fibers resulted in dephospho rylation
and subsequent inactivation of the ErbB family of receptor tyrosine kinases. Additionally ,
it appeared that iron was responsible, at least in part, and that the effect on the receptor
was mediated by internalized fibers . We have identified a potentially important
mechanism by which relevant human lung and pleural target cells respond to asbestos
fibers.

In Chapter 4, iron mobilized from fibers inside human lung epithelial cells was
found to initiate asbestos-induced signaling events preventing survival, but activating
apoptotic pathways. This chapter discusses the effects of asbestos on EGFR-dep endent
and -independent signal transduction pathways in A549 and SAEC cells. Our findings
strongly suggest a central role for the upstream activation of p38 mi to gen-activated
protein kinase (MAPK) in altering the fine balance between cell survival and death . Most
importantly, iron mobilized from fibers inside the cells appeared to initiate the activation
of p38 MAPK leading to apoptosis. We speculate that apoptosis may be an important
response of relevant human lung target cells and that asbestos pathogenesis may result
from altered apoptotic mechanisms.
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Finally , in Chapter 5, we investigated the role of protein phosphatases (PPases)
in asbestos-induced apoptosis in A549 cells, using okadaic acid (OA) and sodium
orthovanadate (VA), specific inhibitors of protein serine/threonine phosphatases
(PSPases) and protein tyrosine phosphatases (PTPases), respectively. Our findings
demonstrated that OA, but not VA, inhibited asbestos-induced global cellular protein
dephosphorylation and apoptosis. Importantly, iron mobilized from fibers inside the cells
and p38 MAPK activity appeared to be required for the increased phosphatase activity
following asbestos treatment. Taken together, our results strongly suggest a critica l role
for PSPases in a p38 MAPK-mediated regulation of asbestos-induced apoptosis in human
lung epithelial cells.
Chapters 3 through 5 in this dissertation are written in the style of the journal in
which they were published or will be published and these chapters include their own
abstract , introduction, materials and methods , and discussion, as well as their own
references .
Chapt er 6 summari zes the results presented in this dissertation and suggests
directions that futur e research in the study of the pathological eff ects of asbesto s may
take .
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CHAPTER2
LITERATURE REVIEW

RELEVANT HUMAN LUNG AND
PLEURAL TAR GET CELLS

The best way to study the effects of asbestos on human lung is the use of actual
lung tissue specimens . However, not only is this approach very expensive, but also is not
useful when doing research that requires living systems . A less expensive and more
practical approach is the use of model systems, e.g. culture of lung cells . There are two
types of cell culture models - primary cultures and cell lines. Primary cultures are
obtained by taking the airway of a donor and preparing it to grow on an artificial
substrate. The advantages of primary culture are that the cells are not modified in any
way. The disadvantages of primary cultures are the mixed nature of each preparation ,
limited lifespan of the culture and the potential contamination problems. A more
convenient and more popular approach is the use of cell lines. Cell lines, which
originated from lung tumors or from a primary culture that is immortalized by
transfection with a virus , e.g. simian virus 40 (SV40) , have an unlimited proliferation
capacity . However, the major disadvantage of cell lines is the fact that they are
genetically modified as compared to normal cells.
Asbestos displays a variety of biological effects in different relevant lung and
pleural target cells, such as mesothelial and epithelial cells . One of the cell lines being
used in the laboratory of Dr. Ann Aust is the tumor cell line A549 . The A549 cells,
human lung epithelial cells, have the same morphology as type II epithelial cells. The
epithelial type II cells are chosen for the majority of these studies because not only did
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they appear at the crossroads of inflammation, fibrogenesis and carcinogenesis, but also
this type of cell is most likely to come into contact with external agents, such as particles
or asbestos fibers.
Another relevant human target cell type sensitive to toxic effects of asbestos are
pleural mesothelial cells. The mesothelial cells are likely to be a target of asbestos fibers,
whether by the direct action of the fiber or by the indirect action of other asbestosexposed cells, e.g. alveolar epithelial cells. Mesothelial cells are very sensitive to the
cytotoxic effects of asbestos (1 ). Asbestos has been shown to cause both chromosom al
aberrations and morphological transformation in human (1) and rodent (2) mesothelial
cells. Since human pleural mesothelial cells from pleural effusions are difficult to
propagate and show individual variability in cytotoxic and genotoxic responses to
asbestos (3, 4), an SY 40 T antigen transformed human mesothelial cell line MET5A has
been used by many investigators (5-7) to study the effects of asbestos on progenit or cells
of mesothelioma.
Since A549 cells were originally derived from an individual with alveol ar
carcinoma tumor, and MET5A cells were immortalized by transfection with a SV40
virus, there is concern that they may not be a faithful representation of normal cells. One
cannot know what changes have occurred in the cells isolated from tumors. Additionally,
the effects of transfection on the cell might sometimes be ambiguous. Although little
work has been done to directly compare the A549s with normal cells, former students in
the laboratory have shown that the A549 cells resembled closely the normal human lung
epithelial cells with regard to ferritin induction and glutathione maintenance (8). Based
on that one would expect to see similar responses to asbestos fibers with respect to other
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experiments. For the purpose of this work, some experiments were performed using
primary cultures of SAEC from the distal airspace to show that all cell culture models
respond similarly to asbestos fibers and that the responses are not an artifact of a single
cell type.

ASBESTOS AND IRON
Epidemiological and animal studies indicate that occupational exposure to
asbestos has been associated with the development of pulmonary fibrosis (asbe stosis),
lung cancer, malignant mesothelioma, and other pulmonary disorders (9). The National
Institutes of Health in 1978 estimated that approximately 11 million individuals had been
exposed to asbestos in the United States since 1940, of which 2000 die from
mesothelioma each year (10) . Due to these health concerns, the use of asbestos has been
limited or prohibited in the United States and in several countries, but in developing
countries, the use of asbestos continues to increase.
Asbestos refers to a group of complex, crystalline mineral fibers that are
endogenous to different geographic areas and occur naturally as ores . Because of their
useful properties such as thermal insulation, chemical and thermal stability, and high
tensile strength, these naturally occurring fibrous silicate minerals have been mined and
processed for decades in a number of countries and incorporated into thousands of
industrial products. The three most common types of asbestos are chrysotile, amosite and
crocidolite. Asbestos differs from other minerals in its crystal development. The crystal
formation of asbestos is in the form of long thin fibers and can only be identified under a
microscope. Asbestos is divided into two mineral groups - serpentine and amphibole. The
division between the two types of asbestos is based upon the crystalline structure .
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Serpentines have a sheet or layered structure while amphiboles have a chain-like
structure. As the only member of the serpentine group, chrysotile is the most common
type of asbestos found in buildings. In the amphibole group, there are five types of
asbestos. Amosite is the second most prevalent type of asbestos found in building
materials. Amosite is also known as "brown asbestos." Next, there is crocidolite or "blue
asbestos," which is an asbestos found in specialized high temperature applications. The
other three types (anthophyllite, tremolite, and actinolite) are rare and found mainly as
contaminants in other minerals . Asbestos deposits can be found throughout the world and
are still mined in Australia, Canada, South Africa, and the former Soviet Union. Asbestos
is made up of microscopic bundles of fibers that may become airborne when distri buted.
These fibers get into the air and may become inhaled into the lungs, where they may
cause significant health problems . Researchers have not yet determined a "safe level" of
exposure but we know the greater and the longer the exposure, the greater the risk of
contracting asbestos-related disease .
Two properties of the asbestos fibers appear to affect their ability to cau se cancer:
physical dimensions and durability (11) . Longer asbestos fibers are mor e biopersist ent,

i.e. accumulate more readily in the lung and are less effectively cleared. Generally , the
longer the fiber resides in the lung, the more likely it is to be carcinogenic. Amphibole
fibers remain in the lung for the lifetime of the individual. Nevertheless , neither size nor
durability can fully account for the chemistry of, and the biological reactions to, mineral
fibers . The pathogenicity associated with exposure to amphiboles, believed to be more
carcinogenic in man than the serpentines, has recently been linked to high iron content
present on the surface of the fibers (11) . Crocidolite and amosite, the most commercially
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used forms of amphibole asbestos, contain high levels of iron (Table 2-1 ). Table 2-1
shows chemical formulas of different types of asbestos. All types may contain different
combinations of ions and metals depending on mining locations. Additionally, complete
ion exchange can occur, e.g. magnesium ions in chrysotile can be replaced with either
iron or manganese, or both.

Table 2-1 Chemical Empirical Formula of Asbestos
Asbestos type

Formula

Content of Iron

Crocidolite

·
( OH)i
Na2Fe 3+2(Fe 2+,Mg )3(S1sO22]

27%

Amosite

2
(Fe +,Mg)7[SisO22](OH)2

27%

Tremolite

Ca2Mgs[SisO22](OH)i

trace

Anthophyllaite

2
(Fe +,Mg)7[SisO22](OH)i

N .D.a

Chrysotile

Mg 3Si2Os(OH)4

2-3%

a not determined

The most carcinogenic forms of asbestos contain as much as 27% iron by weight
(12, 13). It has been shown that iron from asbestos catalyzes the generation of RO S, such
as 0 2 - and -OH (11 , 14). In addition , iron has been shown to be responsible for 0 2
consumption (15), induction of DNA single-strand breaks (16), lipid peroxidation (17) ,
and potentially cancer. There is also significant evidence suggesting that iron from other
sources besides asbestos may cause human cancer ( 18, 19).
Iron is the most important essential trace element in living systems, occurring in
the human body in both Fe (III) and Fe (II) forms (20). It is vital for organisms because it
is required for multiple metabolic processes to include electron transport and cellular
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respiration, cell proliferation and differentiation, as well as regulation of gene
expression (21 ). However, iron is also potentially deleterious. Its excretion from the body
in the absence of bleeding is limited to no more than 4 mg/day, regardless of the quantity
of iron in body stores. In excess of cellular needs iron is toxic and dietary overload
frequently leads to tissue iron deposition and injury (22) . Thus, iron concentration in the
body organs must be regulated carefully. Iron must be bound to proteins to prevent tissue
damage from free radical formation. The following equations show the modified HaberWeiss (Eq. 1-4) and Fenton reactions (Eq. 4):

Reductant (n)+ Fe (III) • Reductant (n+I)+ Fe (II)
Fe (II)+ 02

~

Fe (III)+ 0 2·-

Eq. 1
Eq. 2

H02 · + 02 ·- + H+ • 02 + H202

Eq. 3

Fe (II) + H202 •

Eq. 4

Fe (III) +OH - + ·OH (Fenton Reaction)

Fe (II) acts as a catalyst in the above reaction. This process can be inhibited by free
radical scavengers as well as by iron chelators such as EDT A, formaldehyde, and citric
acid. Iron will continue to redox cycle in the above reactions as long as there is sufficient
02 or H 202 and reductant , such as ascorbate or cysteine .
A free radical is any species capable of independent existence that contains one or
more unpaired electrons. Radicals can be formed by the loss of a single electron from a
non-radical or by the gain of a single electron by a non-radical. Also, radicals can be
formed when a covalent bond is broken if one electron from each of the pair shared
remains with each atom, a process known as homolytic fission . Once the hydroxyl free
radical is created, it reacts virtually immediately. The hydroxyl radical is one of the most
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reactive chemical species known. In contrast to other ROS, such as 0 2·- and H 2O2, -OH
can react with virtually any biological molecule . It reacts within l O A of the site of its
generation, indicating that it must be produced at the site of the damage (11) . ROS
generated by Fenton chemistry can deplete intracellular antioxidants and cause cellular
damage including lipid peroxidation, DNA adducts and protein modifications (11). Also,
they may contribute to major pathological processes such as cancer, arteriosclerosis, and
neurodegenerati ve diseases.

It has been well established that an oxidative environment produces DNA damage
through the mediation of iron ions present in the nucleus (23). Since it has been shown
that iron can be mobilized from asbestos fibers (24) and is capable of inducing DNA
single-strand breaks ( 16), one can suspect asbestos fibers to be a potential source of the
nuclear iron. However, the fibers have rarely been observed in the nucleus. Other
findings suggest the presence of iron in the nucleus including the detection of ferritin, the
iron storage protein, in this organelle (25, 26), and the discovery of both DNA repair
enzymes and transcription factors containing iron-sulfur clusters (27-29) . The iron pool in
the nucleus could be a direct consequence of the cytosolic iron control if iron would
diffuse freely through the nuclear membrane pores . Recently it has been proposed that a
P-type ATPas e, distinct from other known P-type ATP ases, supports iron accumulation
in the nucleus (30) . Even though newer information appeared during recent years that
provided greater insights into factors involved in iron transport into the nucleus, the exact
mechanism and players implicated in it still remain obscure .
There is significant evidence demonstrating the notion that iron was mobilized
from asbestos fibers and was responsible for 0 2 consumption, DNA oxidation and lipid
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peroxidation ( 15-17). It has been proposed that iron mobilized from asbestos into a
LMW fraction, not associated with proteins, led to pathological phenomena, including
cancer. Importantly, it has been found that the reactivity of iron was dependent upon its
electronic environment ( 11). For instance, binding of LMW chelators, including citrate or
ADP, renders iron redox active. In contrast, desferrioxamine B (DF) and phytic acid (PA)
that bind tightly to all of the iron coordination sites making it inert, can prevent ironderived ROS production within cells (31, 32).
Taken together, evidence is accumulating to suggest that iron mobilization in the
cells is of critical importance in asbestos-induced DNA damage and toxicity.

UPTAKE OF ASBESTOS FIBERS
With the exception of mucus cells all airway cells endocytize particles (33). It has
been shown that endocytosis of asbestos fibers and other types of iron-containing
particles is important for particulate-induced toxicity in both mesothelial and epithelial
cells (34-36). Liu et al. (34) have demonstrated an important role for asbestos
endocytosis in a wide range of asbestos pathogenic effects, such as intracellular
oxidation, DNA strand breakage and apoptosis . Furthermore, it has been shown that
endocytosis of crocidolite asbestos in A549 cells was required for iron mobilization from
asbestos fibers into a LMW fraction, ferritin induction and asbestos-dependent biological
effects (35, 36). Nevertheless, the mechanism by which fibers are internalized is not well
understood. Recently, Boylan et al. (37) observed that asbestos fibers could be
internalized into the cells through association with the extracellular glycoprotein
vitronectin via integrin membrane receptors.
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EPIDERMAL GROWTH FACTOR
RECEPTOR
Although the mechanism by which asbestos exerts its pathologic effects is not
known, it is possible that asbestos-induced pulmonary toxicity might be initiated by
interaction of asbestos fibers with the plasma membrane through a receptor-like
mechanism (38) .
Epidermal growth factor receptor belongs to the ErbB family of four closely
related cell membrane receptors: EGFR (HERi or ErbBl), ErbB2 (HER2), ErbB3
(HER3), and ErbB4 (HER4). These receptors are transmembrane glycoproteins that
consist of three main regions: an extracellular ligand-binding part, a hydrophobic
membrane-spanning region, and a cytoplasmic portion containing the tyrosine kinase.
Activation of the EGFR occurs when a ligand, such as epidermal growth factor (EGF) ,
binds to its extracellular domain . This causes the receptor to dimerize with either another
EGFR monomer or with another member of the ErbB family (39) . Following receptor
dimerization, activation of the intrinsic protein tyrosine kinase activity and tyrosine
autophosphorylation occur. The carboxy terminal tyrosine residues on EGFR, tyrosine
1068 and tyrosine 1173, are the major sites of autophosphorylation. All phosphorylated
tyrosines serve as docking sites for signaling molecules containing Src homology 2 (SH2)
domains, e.g. Grb2, or phosphotyrosine-binding (PTB) domains, e.g. She. Cytoplasmic
mediators which bind to EGFR phosphotyrosine residues through SH2- or PTB-domains
may either be adaptor proteins or enzymes. EGFR mediates the binding through direct
interactions with phospho-tyrosine 1068 and phospho-tyrosine 1086 and through indirect
interactions with phospho-tyrosine 1173. Tyrosine 1173 of EGFR also functions as a
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kinase substrate (40). Phosphorylation of tyrosine 992, tyrosine 1068 and tyrosine
1086 is required for conformational change in the C-terminal tail of the EGF receptor
(41 ). The events of recruitment and phosphorylation of various signaling proteins lead to
subsequent activation of many different downstream signaling pathways. It has been
shown that a variety of stresses, including both chemical and physical agents, can activate
EGFR. These include ultraviolet rays (42), hydrogen peroxide (H2 0 2) (43) and asbestos
fibers (38, 44-47). Activation of the EGFR has been shown to enhance processes
responsible for tumor growth and progression, including the promotion of proliferation ,
angiogenesis, invasion/metastasis, and inhibition of apoptosis. These effects are mediated
by a complex series of signaling mechanisms, such as engagement of the MAPK and
phosphatidylinositol-3 kinase (PI3K) pathways. Inactivation of the EGFR can lead to G 1
arrest (48) and apoptosis (49). Both activation and inactivation of the EGFR are
associated with pathological effects.
Activation of the receptor by EGF also leads to rapid internalization of the
receptor through clathrin-coated pits (reviewed in (50)) . After internalization, EGFreceptor complexes appear sequentially in early endosomes and multivesicular bodies .
During passage through the endosomal compartments, these complexes are either
recycled back to cell surface or sorted to late endosomes and lysosomes, where both EGF
and EGFR are proteolytically degraded. The accelerated internalization and efficient
lysosomal targeting of EGF-occupied receptors result in a dramatic degradation of the
EGFR protein in the presence of EGF. Interaction of the receptor with the ubiquitin ligase
c-Cbl has been shown to be essential for efficient removal of the activated receptors from
the cell surface ("down-regulation") ( 51). Recently this interaction has also been shown
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to depend upon receptor phosphorylation at tyrosine 1045, the major docking site for cCbl (52). This binding results in the activation of the ubiquitin ligase activity of c-Cbl.
The latter of these events promote the recruitment of the ubiquitin-conjugating enzyme
UbcH7 (53) and the subsequent receptor monoubiquitination, which targets the receptor
to lysosomal degradation. In addition to lysosomal degradation, several other
mechanisms of receptor degradation have been proposed, e.g. by proteasome (54),
calpain-mediated pathways (55), and caspase-mediated EGFR degradation during the
early phase of cell death (56). Importantly, Opresko et al. (57) have shown that
endocytosis and lysosomal targeting of EGFR are mediated by distinct sequences
independent of the tyrosine kinase domain.
The majority of studies of interaction between asbestos and EGFR have been
done in rodent cells or rodents, i.e. rat pleural mesothelial (RPM) cells (38, 45, 58),
murine alveolar type II epithelial (ClO) cells and transgenic mice (47) . The treatment of
rodent cells led to increased expression, phosphorylation and subsequent activation of the
EGFR, leading to cell injury (apoptosis) and/or proliferation . Inhibition of the asbestosinduced phosphorylation of EGFR blocked the development of apoptosis in RPM cells.
Studies with human cells are very limited and involve investigation of EGFR on the
plasma membrane using only microscopy (44). In an imrnunohistochemical study of
EGFR after treatment of MET5A cells and A549 cells with long ( 2'::60 µm) asbestos
fibers, MET5A cells showed patterns of aggregation and increases in EGFR protein while
no effects were observed in A549 cells. It was concluded that this might be due to some
differences in sensitivity to cytotoxic effects of asbestos and/or different mechanisms of
response between mesothelial cells and epithelial cells.
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MITOGEN-ACTIV ATED PROTEIN
KINASE AND
PHOSPHATIDYLINOSITOL
3-KINASE-AKT SIGNALING
Protein kinases are enzymes that covalently attach phosphate to the side chain of
either serine, threonine, or tyrosine of specific proteins inside cells . Such phosphorylation
of proteins can control their enzymatic activity, their interaction with other proteins, their
location in the cell, and their susceptibility for degradation by proteases. Less than fifteen
years ago, researchers discovered a group of novel protein kinases, now known as
MAPKs. From that time, studies of the MAPK superfamily have grown explosivel y and
have significantly contributed to our understanding of the regulation of growth and
development and the mechanisms by which cells respond to external stresses. MAPKs
have crucial roles in cellular responses to various extracellular signals (59). Their
function and regulation have been conserved during evolution from unicellular organisms
to complex organisms including humans (60). They regulate cellular activities ran ging
from gene expression, mitosis, movement, metabolism , and programmed death . They
belong to a large family of pro line-directed serine/threonine kinases that are the terminal
kinases of three-tiered kinase modules consisting ofMAPKKK (MAP kinase kinase
kinase), MAPKK, and MAPK (61) . Full activation of MAP kinases requires dual
phosphorylation of a tyrosine and a threonine within a Thr-X-Tyr (where Xis glutamate ,
proline and glycine in extracellular signal-regulated kinases (ERK.s), c-Jun N-terminal
kinases (JNKs) and p38 MAPKs, respectively) motif in the activation loop. This is
performed by dual specificity kinases, the MAPKK, which are themselves activated by
phosphorylation by MAPKKK. The MAPKKK are activated by either phosphorylation or

by interaction with a small GTPase of the Ras or Rho family. There are three well-
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characterized subfamilies of MAPKs. These MAPKs include the extracellular-regulated
kinases, ERKl and ERK2, the c-Jun kinases, JNK I, JNK 2, and JNK 3, and the five p38
enzymes, p38a, p38,B, p38y, p38S, and p38-2. A fourth MAPK, ERK5, is a relatively
recently identified MAPK and is being currently studied (62). Additionally, there are
several possible MAPK candidates that are still not well characterized, e.g. ERK7 (63).
The ERK module responds primarily to growth factors and mitogens and stimulates
transcriptional responses in the nucleus. ERKI and ERK2 are activated by MAPK/ERK
kinase (MEK) 1 and MEK2, which phosphorylate at the threonine-glutamate-tyrosine
motif (64). The MEKs, in tum, are activated by c-Raf, the MAPKKK of this signaling
pathway that is in tum regulated by growth factor receptors and tyrosine kinases
activating through Ras (65) . Upon translocation to the nucleus, ERKs are responsible for
the phosphorylation of multiple substrates, including activators of transcription, e.g.
p90Rsk kinase, as well as transcription factors, e.g. Elk-1 (66). Generally, activation of
ERK signaling pathways has a role in mediating cell division, migration, and survival.
There are five p38 isoforms (a,

/J,r, Jand

p38-2) that differ based on their

substrate specificity. The p38a enzyme is the best characterized and perhaps the most
physiologically relevant kinase involved in inflammatory responses. p38 MAPK is
activated by dual phosphorylation on Thr180 and Tyrl82 by an upstream MAPKK
termed MAP2K6 (also known as MKK6). Other MAPKKs, such as MAP2K3 (also
known as MKK3), have also been suggested to activate p38 MAPK. Recently, a
MAPKK-independent mechanism of p38 MAPK activation has been described (67). The
p38 MAPKs are generally activated by environmental stresses, including heat, osmotic

and oxidative stresses, ionizing radiation, as well as inflammatory cytokines and tumor
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necrosis factor (TNF) receptor signaling (68). Downstream of p38 MAPK there is a
diversification and extensive branching of signaling pathways. The substrates of p38
MAPKs include other kinases, cytosolic proteins and transcription factors (69, 70). The
p38 MAP kinases regulate the expression of many cytokines, have an important role in
activation of the immune response, and are involved in affecting cell motility,
transcription and chromatin remodeling (70) . Also, p38 MAPK is required for the
induction of apoptosis by diverse stimuli such as UV irradiation, osmotic shock , and
oxidants (71-73). Although the precise mechanism by which p38 MAPK induces cell
death in unclear, blockade of this kinase has been shown to be protective against a variety
of apoptotic stimuli (74). Finally, p38 MAPKs appear to be involved in human diseases
such as asthma and autoimmunity.

In recent years, it has been shown that survival signals induced by several
membrane receptors are mediated mainly by PI3K/ Akt pathway . The Akt, or protein
kinase B (PKB), has recently been a focus of intense research. Akt is a serine/threonine
kinase , which in mammals comprises three highly homologous members known as

PKBa (Aktl), PKB/J (Akt2), and PKBy(Akt3) . Akt is activated in cells exposed to
diverse stimuli such as hormones, growth factors, and extracellular matrix components.
The activation mechanism remains to be fully characterized but occurs downstream of
PBK . PBK generates phosphatidylinositol-3,4,5-trisphosphate

(PIP 3), a lipid second

messenger essential for the translocation of Akt to the plasma membrane where it is
phosphorylated and activated by phosphoinositide-dependent kinase 1 (PDKl) and
possibly other kinases. Akt phosphorylates and regulates the function of many cellular
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proteins involved in processes that include metabolism, cell cycle progression, cellular
growth, cell survival and apoptosis. It appears that A.kt lies in the crossroads of multiple
cellular signaling pathways and acts as a transducer of many functions initiated by
growth factor receptors . In addition, the recent discovery of the tumor suppressor PTEN
as an antagonist of PBK and A.kt kinase activity suggests that A.kt is a critical factor in
the genesis of cancer. Studies conducted over the last years show that A.kt is critical for
cell survival triggered by growth factors, extracellular matrix, and other stimuli (75).
Generally, in contrast to p38 MAPK signaling, phosphorylation of A.kt substrates results
in antiapoptotic effects (76) .
Several independent research groups have provided evidence for the involvement
of some signaling cascades in rodent cells following asbestos exposure (38, 77, 78). For
instance, Jimenez et al. (79) have observed that asbestos-induced RPM cell toxicity was
associated with activation of ERK , but not JNK/SAPK pathways . However , the effects of
asbestos on the control and coordination of the signal transduction pathways in human
lung cells have not been investigated. The results reported herein (Chapter 3 and 4) reveal
not only important speci es differences but also the comple xity and diversity of regulatory
mechanisms in asbestos-induced signaling events .

PROTEIN PHOSPHATASES

It has been estimated that one third of all proteins in an organism , i.e. close to
10,000 proteins in humans, undergo reversible phosphorylation, often at multiple sites
(80). Target proteins are phosphorylated at specific serine, threonine, or tyrosine residues
(there is also evidence for histidine phosphorylation) by protein kinases and the
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phosphate group is removed by the action of specific PPases . Over 98% of all
phosphorylations occur on serine and threonine residues, whereas the remaining less than
2% affects tyrosines. Phosphorylation and dephosphorylation of proteins mediate signal
transduction events that control a multitude of cellular processes including metabolism,
transport, cell division, differentiation and development, learning and memory (81, 82).
PPases are classified based on their substrate specificity, dependence on metal ions, and
sensitivity to inhibitory agents. There are two main classes of PPases according to their
substrate specificity, i.e. PTPases and PSPases, which remove phosphate from proteins
containing phosphotyrosine or phosphoserine/phosphothreonine, respectively.
Interestingly, PTPase family includes both tyrosine-specific and dual specificity
phosphatases (DSPases) that remove phosphate from proteins containing all three
phosphoamino acid residues.
PSPases are divided into two groups, type 1 and type 2, depending on whether
they dephosphorylate the /Jsubunit of phosphorylase kinase specifically and are inhibited
by nanomolar concentrations of two small heat- and acid-stable proteins, termed inhibitor
1 (I-1) and inhibitor 2 (I-2) (type l, PPl), or whether they dephosphorylate the a subunit
of phosphorylase kinase preferentially and are insensitive to I-1 and I-2 (type 2, PP2).
The type 2 phosphatases could, in turn, be subdivided into three distinct enzymes, PP2A,
PP2B, PP2C, in a number of ways, but most simply by their dependence on divalent
cations. PP2B and PP2C had absolute requirements for Ca (II) and Mg (II), respectively,
while PP2A (like PPl) was at least partially active toward most substrates in the absence
of divalent cations (83, 84).
PSPases have been shown to regulate apoptosis. Although inhibitors of PPl and
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PP2A, such as OA and calyculin A, induce apoptosis in some cell lines (85, 86),
inhibition of apoptosis by these agents has also been reported (87-90). Inhibition of PP2A
has been shown to block poly(ADP-ribose) polymerase (P ARP) cleavage, a caspase-3
substrate (91). In addition, PPl inhibition suppressed the ceramide-induced alternative
splicing of specific apoptotic factors, caspase-9 and Bcl-x (89) .
Like protein tyrosine kinases, PTPases constitute a large family of enzymes (92).
PTPases can exert both positive and negative effects on a signaling pathway and play
crucial physiological roles in a variety of mammalian tissues and cells (93). Unlike
protein tyrosine kinases, however, which share sequence identity with protein
serine/threonine kinases, the PTPases show no sequence similarity with the PSPases.
PTPases are characterized by the presence of the active site signature motif
(HN)C(X)sR(S /T) in the conserved catalytic domain (94). In addition to the catalytic
domain, PTPases are decorated with a wide range of structural elements includin g SH2
domains , extrac ellular ligand binding domains , and many others (95) . A recent estimate
from the nearly completed human genome sequence suggests that humans have 112
PTPases (96), which include both the tyrosine -specific and dual-specificity pho sphatases.
The tyrosine-specific phosphatases, such as PTPlB, hydrolyze phosphotyrosinecontaining proteins, while the dual-specific phosphatases, such as Cdc25 , can utilize
protein substrates that contain phosphotyrosine , as well as phosphoserine and
phosphothreonine. The tyrosine-specific PTPases can be further categorized into two
groups: receptor -like and intracellular. The receptor-like PTPases, exemplified by CD45,
generally have an extracellular putative ligand-binding domain, a single transmembrane
region, and one or two cytoplasmic PTP domains. The intracellular PTPases, exemplified
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by PTPlB, contain a single catalytic domain and various amino or carboxyl terminal
extensions including SH2 domains that have targeting or regulatory functions. Examples
of dual-specificity phosphatases include the MAP kinase phosphatases, the cell cycle
regulator cdc25 phosphatases, and the tumor suppressor PTEN. All PTPases are
characterized by their sensitivity to vanadate, ability to hydrolyze p-nitrophenyl
phosphate, insensitivity to okadaic acid, and lack of metal ion requirement for catalysis.
Several findings suggest that PTPases could be actively involved in the induction
of apoptosis. Activation of PTPases inhibited cellular growth of human renal and breast
carcinoma cells (97). Meredith et al. (98) found that apoptosis was blocked by treating
cells in suspension with the tyrosine phosphatase inhibitor sodium orthovanadate, and
this effect was reversed by the tyrosine kinase inhibitor herbimycin A. Microinjection of
MAP kinase phosphatase 1 has also been shown to inhibit ras-induced DNA synthesis in
rat fibroblasts (99), and several other factor inhibited cell proliferation by stimulating
PTPases (100).

REDOX SIGNALING

Growing evidence indicates that reduction-oxidation (redox) status can regulate
various aspects of cellular function. It affects cell growth and functions via modulating or
utilizing signaling pathways from cell surface receptors. In addition, in several signaling
cascades ROS themselves may act as an intracellular signaling system (101). In addition
to direct damage, generation of ROS may lead to excessive signals to the cells resulting
in cell death or pathological processes in which ROS are involved. The redox state of the
cell is primarily a consequence of the precise balance between the levels of oxidizing
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ROS and reducing equivalents. To counteract the effects of ROS, cells have developed
two important defense systems mechanisms: a thiol reducing buffer consisting of small
proteins with redox-active sulfhydryl moieties, e.g. glutathione (GSH) and thioredoxin
(TRX), and enzymatic systems, e.g. superoxide dismutase, catalase, and glutathione
peroxidase (102). In recent years it has become clear that this finely tuned cellular redox
state can be modulated under several conditions, e.g. oxidative stress. The term oxidative
stress has rarely been defined in a universally accepted way. One accepted definition by
Sies et al. (103) is a disturbance in the pro-oxidant - antioxidant balance in favor of the
former, leading to potential damage. Oxidative stress has been implicated in a variety of
human diseases including atherosclerosis, diabetes, arthritis, cancer, and
neurodegenerative disorders (104). In higher eukaryotes, ROS can be generated when
oxygen is partially reduced as electrons leak out of the electron transport chain during
respiration in mitochondria . Oxidative stress can also originate from other tissues or from
neighboring cells, as well as from the extracellular stimuli, e.g. asbestos fibers. The most
common forms of ROS include 0 2 ·- , H 20 2 , and the highly reactive -OH. ROS have been
implicated in the regulation of diverse cellular functions including defense against
pathogens, proliferation and apoptosis. Additionally, several lines of evidence have
indicated that the cellular redox state plays an essential role in many cellular signaling
systems ( 105-108). Cells respond to their environment and carry out specific functions
through highly organized and tightly regulated networks of signaling pathways that
encompass kinases, phosphatases, adapter and scaffold proteins, and others that produce
or respond to small diffusible molecules called second messengers . There is growing
body of evidence that supports a role for ROS as second messengers and critical
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modulators of protein phosphorylation and gene transcription. Exposure of cysteine
residues to ROS can give rise to a variety of different reaction products , and the stability
of a given product depends on the local environment of the thiol involved (109).
The distinctive characteristic of EGFR is the presence of two-cysteine rich
sequence repeat regions within the extracellular domains of these receptors. Strict
conservation of cysteine residue spacing and similarity of interspersed sequences suggest
functional significance for a disulfide-linked structural motif (110). It is believed that the
function of EGFR depends on intra- and intermolecular S-S bridges (111). It has been
suggested that oxidation of the reactive SH-groups enhances receptor activation while
reduction ofrelevant S-S bridges leads to its inactivation (112, 113). Interestin gly, it has
been observed that iron-derived ROS, directly or indirectly, led to receptor
dephosphorylation (see Chapter 3). Since H 2O 2 activates, rather than inactivates , EGFR
activity (43, 114), this observation may seem somewhat controversial. Howev er, H 20

2

and iron-derived ROS differ markedly in their reactivity with cellular molecules , whic h
might explain that inconsistency . Hydrogen peroxide is only mildly reactive and thus
reacts sluggishly with biomolecules (115) . On the other hand , iron can generat e reacti ve
oxygen species via the sequential, one electron reductions of molecular oxygen to
produce the highly reactive hydroxyl radical that can react with almost any biological
molecule. In addition, iron as a catalyst in these reactions may continue to cycle
indefinitely through a series of Haber-Weiss reactions (11). One plausible mechanism by
which iron-derived ROS may lead to EGFR dephosphorylation is through activation
and/or recruitment of protein phosphatases that dephosphorylate and inactivate the
EGFR .
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Although cells have antioxidant enzymes and some reducing systems, e.g. GSH
and Trx, ROS can produce transient changes in the cellular redox state , particularly, in
the redox state of cysteinyl thiols, which can affect the activity, the protein-protein and
DNA-protein interactions of enzymes and transcription factors. Evidence has recently
accumulated in support of a role of ROS in the modulation of PPase activity . PTPases
contain in their active site a cysteine (CX5R) that is essential for their activity and can be
modified by oxidation. This cysteine is particularly reactive with H 20 2 because the
surrounding residues in the active site allow for its ionization to a thiolate. React ion of
the thiolate with H 20 2 leads to inactivation of the PTPases. This intermediate quickly
reacts with a thiol (-SH) such a GSH to produce a disulfide in the PTPases, a form that is
also catalytically inactive. Data obtained in vivo and in vitro indicate that H20 2 can
specifically and reversibly inactivate PTPases (116, 117). Interestingly, it has recently
been demonstrated that a PPase regulated the dephosphorylation of tyrosin e residues,
directly or indirectly , in the oxidative stress-mediated inactivation of EGFR (56). This
finding was very unusual since, as mentioned above, oxidation of critical cysteine
residues within PPases catalytic sites leads to their inactivation rather than activation
(118). However , it has been speculated that a sphingolipid ceramide could be a possible
intermediate between singlet oxygen and activation of PPases (56). It has been shown
that singlet oxygen induces rapid ceramide production, and moreover, that ceramides
activate PPases (119). Additionally, oxidative stress has been shown to activate p38
MAPK (120), which in tum may activate PPases (121) . Thus, p38 MAPK could also link
production of ROS and activation of PPases.
Many studies have shown that exposure to oxidative stress leads to activation of

28
the MAP kinases (106, 120, 122-124). The mechanisms by which exogenous or
endogenous produced ROS activate the MAP kinases are not well defined. Several
mechanisms have been proposed for p38 MAPK activation that involve ROS-dependent
dissociation of a signalosome that maintains the pathway in an inactive state. ASKl, a
MAPKKK for p38 MAPK associates with reduced Trx in non-stressed cells . Oxidation of
Trx by ROS releases ASK-1, and leads to p38 MAPK activation (125).
Activation of some MAP kinases could also be the result of activation of the Src
kinase family. c-Src was found to be required for the H 2Oi-induced activation of ERK.5
(126) while Fyn, another member of the Src family, appears to be involved in the H2Oiinduced activation of ERKl/2 (127). Additionally, the DSPases that control the activity
of the MAP kinases also contain the cysteine signature motif, although the role of ROS in
modulating their activity has not yet been extensively explored (128). Taken together,
despite a great deal of work that has been done in this field , the exact mechanisms for the
redox sensitivity of these kinases are not known.

APOPTOSIS AND CANCER
Programmed cell death, or apoptosis , is recognized as a critical element during
normal development and in the removal or elimination of cells following exposure to
toxic compounds, without affecting neighboring cells or eliciting an inflammatory
response. This process of programmed cell death is characterized by marked chang es in
cell morphology including chromatin condensation, membrane blebbing, nuclear
breakdown, appearance of membrane-associated apoptotic bodies, as well as by
intemucleosomal DNA fragmentation and cleavage of many housekeeping proteins, e.g.
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PARP. In the last decade, much progress has been made towards elucidating the
various signal transduction pathways that can ultimately lead to cell death . Many
apoptotic cascades have been described, such as mitochondrial and death receptor as well
as p53-dependent and - independent pathways, in association with initiation,
commitment, and execution phases. It has become clear that apoptosis is not a series of
clearly defined pathways, but rather , a multitude of highly regulated, interconnected
pathways . The intrinsic cell death pathway involves the initiation of apoptosis as a result
of a disturbance of intracellular homeostasis. In this pathway, mitochondria are critical
for the execution of cell death and therefore this pathway has also been referred to as the
mitochondrial cell death pathway. The extrinsic pathway involves the initiation of
apoptosis through ligation of plasma membrane death receptors and therefore this
pathway is also referred to as the death receptor pathway . While the initiation
mechanisms of these pathways are different, both converge to result ultimately in cellular
morphological and biochemical alterations characteristic of apoptosis .
Caspases, cysteine aspartate -specific proteases, are family of intracellul ar proteins
involved in the initiation and execution of apoptosis . To date , at least 14 mamm alian
caspases have been identified . Caspases are synthesized as procaspas es that are then
proteolytically processed , at critical aspartate residues, to their active forms . The
induction of apoptosis through extrinsic or intrinsic death mechanisms results in the
activation of initiator caspases, i.e. caspases 2, 8, or 10 (extrinsic pathway) and caspase 9
(intrinsic pathway). Activation of initiator caspases is the first step of a highly regulated ,
irreversible, self-amplifying proteolytic pathway. Initiator caspases are able to cleave
procaspases, and thus , are able to activate effector caspases (caspases 3, 6, and 7).
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Effector caspases are common to both the extrinsic and intrinsic pathways, and that is
why the ultimate morphological and biochemical hallmarks of apoptosis are relatively
independent of the apoptotic inducer.
PARP, a 116 kDa nuclear poly(ADP-ribose) polymerase, appears to be involved
in DNA repair predominantly in response to environmental stress (129). PARP is thought
to be one of the earliest targets for cleavage by caspase-3-like proteases during apoptosis.
The cleavage of PARP between Asp214 and Gly215 results in separation of the two
DNA-binding motifs in the NHi-terminalregion of the enzyme and renders PARP
inactive. With the use of a caspase-3-resistant PARP mutant, it has been shown that
cleavage of PARP plays an important role in the normal progression of apoptosis (130) .
The cleavage of PARP has been suggested to occur to prevent depletion of the energy
reserves, i.e. ATP, that are thought to be required for the later stages of apoptosis, and to
prevent futile repair of DNA strand breaks during the death program . Cleavage of PARP
has also been suggested to facilitate cellular disassembly and serves as a marker of cells
undergoing apoptosis ( 131).
Upon binding its receptor, EGF activates EGFR and initiates signal transduction
cascades including the cellular components such as PI3K/ Akt and MAPK . Generally,
EGF-like growth factors concomitantly activate these two pathways, whereas EGFR
inhibition suppresses both signaling cascades (48). Depending on the cell type and the
duration and strength of the stimulus, these pathways are often activated simultaneously
with apparently conflicting responses such as apoptosis and proliferation ( 132).
Generally, however, activation of PI3K/Akt and MAPK signaling pathways plays a role
in mediating cell survival. The cytosolic serine/threonine protein kinase Akt is considered
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the focal point of a survival pathway known to protect cells from apoptosis during
cytokine and growth factor stimulation. Activated Akt has also been shown to delay the
onset of p53-mediated transcriptionally dependent apoptosis (133). It has become evident
that ErbB receptor blockade results in interruption of constitutive MAPK and PI3K/ Akt
signaling, reversible Gl arrest, and apoptosis (134, 135). Recent evidence has pointed to
a relationship between the Akt and MAPK survival pathways and the structurally similar
stress-activated members of the MAPK family, which includes p38 MAPK pathway. It
has been shown that activation of ERK functions to protect cells from oxidative stressinduced apoptosis, while activation of p38 MAPK signaling plays a proapoptotic role in
this process. There is growing evidence suggesting cross-talk between p38 MAPK
pathway and ERK and Akt pathways in a variety of eukaryotic cells. It seems as if the
dynamic balance among PBK/Akt, ERKI/2 and p38 MAPK pathways may govern the
ability of cells to survive or undergo apoptosis (136). It has been observed that blockade
of PBK/Akt and ERKl /2 pathways with concurrent activation of the p38 MAPK
pathway suppressed cell survival and subsequently stimulated apoptosis in HeLa cells
(137) . The exact cellular mechanism underlying the cross-talk between p38 MAPK and
ERK and Akt pathways remains unknown. It is clear though that regulation of these
proteins involves a dynamic interplay between kinases and phosphatases.
Growing evidence suggests that apoptosis is regulated by the active PPases .
Activation of PPases has been implicated in dephosphorylation of a number of survival
proteins including Akt and ERKl/2 (138, 139), and furthermore, inhibition of PPases led
to activation of MEK and ERK.1/2 (140). Recent studies have also demonstrated that
activation of p38 MAPK by arsenite blocked the activation of survival ERKI/2 via a
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PSPase in NIH 3T3 fibroblasts (121) . In addition, caspase-3 has been shown to be
associated with altered phosphatase activity. Caspase-3 directly cleaves the PP2A
regulatory A subunit thereby increasing phosphatase activity (141), and inhibition of
PP2A blocks P ARP cleavage (91 ). Finally, PPase inhibition has been shown to suppress
the ceramide-induced alternative splicing of specific apoptotic factors, caspase-9 and BelX

(89).
It is now widely recognized that cancer is not simply a proliferative disease, but

the manifestation of an imbalance between cell growth and cell death . In light of the
critical importance of apoptosis in the regulation of tissue growth, one may speculate that
alterations in this pathway may be an important factor in tumorigenesis. It is not clear ,
however, what role, if any, apoptosis may play in the early stages of carcinogenesis. One
possibility is that an active pathway leading to apoptotic cell death may simply be
overcome . Also, some cells may exhibit preexisting genetic insensitivity to induction of
apoptosis. Furthermore, the carcinogen-induced apoptosis could play a passive role in
carcinogenesis by indirectly stimulating cells in the area around the site of apoptosis
(which may contain sub lethal but mutagenic levels of damage) to proliferate . In this way
apoptosis would not differ from necrosis or wounding in facilitating tissue regeneration
and expansion of potentially mutagenized cells. Another possibility is that defective
apoptosis may permit the persistence of damaged, mutated cell that would otherwise have
been deleted . Importantly, for neoplastic growth to occur, an imbalance between
proliferation and apoptosis must be established such that cell growth predominates.
Studies by others have demonstrated asbestos-induced apoptosis in both rodent
(38, 77, 142-144) and human (142, 145-147) lung cells. The mechanism of asbestos-

33
induced apoptosis in the lung cells is not entirely known. Studies in rodent cells and
rodents provided some insights into the signal transduction pathways involved in
asbestos-induced apoptosis. Mossman and coworkers have shown that in addition to
mitochondrial-regulated

pathways (77), apoptosis was associated with signaling through

EGFR and subsequent activation of the ERKl/2 cascades (45) . Additionally, Swain et al.
(78) have suggested an important role for p38 MAPK in asbestos-induced cytotoxicity in
RPM cells. Since some differences were reported in the way rodent and human cells
responded to asbestos fibers (Chapter 3 and 4), it is of great importance to examine and
compare the asbestos-induced signaling events in human lung epithelial cells. Kamp and
coworkers have established that asbestos induces apoptosis in human lung epithelial cells
(145-14 7). It was proposed that apoptosis resulted from mitochondrial dysfunction and
was, in part, due to iron-derived ROS. Nevertheless, the signaling cascades involved in
asbestos-induced apoptosis in human cells have not been thoroughly explored.
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CHAPTER3
ROLE OF IRON IN INACTIVATION OF EGFR AFTER ASBESTOS
TREATMENTOFHUMANLUNGAND
PLEURAL TAR GET CELLS

ABSTRACT
Occupational exposure to asbestos has been associated with increased incidence
of pulmonary interstitial fibrosis, mesothelioma of the pleura, and bronchogenic
carcinoma. Although the mechanism by which asbestos causes cancer remains unknown,
iron associated with asbestos is thought to play a role in the pathogenic effects of fibers.
Here, we examined the effects of asbestos on the epidermal growth factor receptor
(EGFR) in human lung epithelial (A549) cells, human pleural mesothelial (MET5A)
cells, and normal human small airway epithelial (SAEC) cells. Treatment of A549,
MET5A and SAEC cells with asbestos caused a significant reduction of EGFR tyrosine
phosphorylation . This was both time- (15 min to 24 h) and concentration-dependent (1.5,
3 and 6 µg/cm

2

)

in A549 cells . Also, treatment with 6 µg/cm 2 crocidolite for 24 h

diminished the phosphorylation levels of human epidermal growth factor receptor 2
(HER2) . In contrast to treatment with 100 ng/ml epidermal growth factor for 15 min,
exposure of A549 cells to 6 µg/cm 2 crocidolite for 3 to 24 h resulted in no detectable
Yl 045 phosphorylation and no apparent degradation of the EGFR. Inhibition of fiber
endocytosis resulted in a considerable inhibition of EGFR dephosphorylation. Most
importantly, removal of iron from asbestos by desferrioxamine B or phytic acid inhibited
asbestos-induced decreases in EGFR phosphorylation. The effects of crocidolite, amosite,

56
and chrysotile on the EGFR phosphorylation state appeared to be directly related to the
amount of iron mobilized from these fibers. These results strongly suggest that iron plays
an important role in asbestos-induced inactivation of EGFR. This inactivation may be
involved in events leading to apoptosis.

INTRODUCTION
Asbestos is a naturally occurring mineral that has been used for centuries because
of its unique physical and chemical properties, including durability, tensile strength, and
heat resistance. However, it was recognized to be a human carcinogen in the late 1950s.
Exposure to asbestos increases the risk of mesothelioma of the pleura and bronchogenic
carcinoma of the lungs. Even though the molecular mechanism by which asbestos exerts
these effects is not fully understood, the carcinogenicity of asbestos has been related to
some of its physical properties, such as size and durability of fibers ( 1). The most
carcinogenic forms of asbestos contain as much as 27% iron by weight. It has been
shown that iron from asbestos catalyzes the generation ofreactive oxygen species (ROS),
such as superoxide radical (0 2 - ) and hydroxyl radical (·OH) . In addition, iron has been
shown to be responsible for 0 2 consumption, induction of DNA single-strand breaks,
lipid peroxidation, and potentially cancer. There is also significant evidence suggesting
that iron from other sources besides asbestos may cause human cancer.
Although the mechanism by which asbestos exerts its pathologic effects is not
known, at least two plausible mechanisms should be considered. Asbestos-induced
pulmonary toxicity might be initiated by ROS generated from mobilized iron via HaberWeiss reactions ( l ), and possibly by interaction of asbestos fibers with the plasma
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membrane through a receptor-like mechanism (2) .
Epidermal growth factor receptor (EGFR/ErbB 1) is a transmembrane protein with
intrinsic tyrosine kinase activity that is stimulated upon ligand binding. EGFR activation
involves homo- and heterodimerization with other members of ErbB receptor family,
such as ErbB2 (HER2), transphosphorylation of receptors, recruitment of various
signaling proteins, and subsequently activation of many different downstream signaling
pathways. It has been shown that a variety of stresses, including both chemical and
physical agents, can activate EGFR. These include ultraviolet rays (3), hydrogen peroxi de
(H 2O 2) ( 4) and asbestos fibers (2, 5-8) . Inactivation of the EGFR can lead to G 1 arrest (9)
and apoptosis (10). Both activation and inactivation of the EGFR are associated with
pathological effects.
The majority of studies of interaction between asbestos and EGFR have been
done in rodent cells or rodents, i.e. rat pleural mesothelial (RPM) cells (2, 6, 11), murine
alveolar type II epithelial (C 10) cells and transgenic mice (8) . The treatment of rodent
cells led to increased expression, phosphorylation and subsequent activation of the
EGFR, leading to cell injury (apoptosis) and/or proliferation . Inhibition of the asbestosinduced phosphorylation of EGFR blocked the development of apoptosis in RPM cells .
Studies with human cells are very limited and involve investigation of EGFR on the
plasma membrane using only microscopy (5) . In an immunohistochemical study of
EGFR after treatment of human pleural mesothelial (MET5A) cells and human lung
epithelial (A549) cells with long ( ~ 60 µm) asbestos fibers, MET5A cells showed
patterns of aggregation and increases in EGFR protein while no effects were observed in
A549 cells. It was concluded that this might be due to some differences in sensitivity to
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cytotoxic effects of asbestos and/or different mechanisms of response between
mesothelial cells and epithelial cells.
The purpose of this study was to investigate and compare the effects of asbestos
fibers on the EGFR activity in relevant human lung and pleural target cells, i.e. epithelial
(A549 and small airway epithelial cells (SAEC)) and mesothelial (MET5A) cells, and to
determine if iron associated with fibers plays some role in this process. Our results
indicated that in contrast to rodent cells, treatment of human lung epithelial and pleural
mesothelial cells with asbestos fibers resulted in dephosphorylation and subsequent
inactivation of the ErbB family of receptor tyrosine kinases. Additionally, it appeared that
iron was responsible, at least in part, and that the effect on the receptor was mediated by
internalized fibers. We have identified a potentially important mechanism by which
relevant human lung and pleural target cells respond to asbestos fibers.

MATERIALS AND METHODS
Asbestos and Reagents. Crocidolite, amosite and chrysotile fibers were obtained
from Dr. Richard Griesemer, National Institute for Environmental Health
Sciences/National Toxicology Program (Research Triangle Park, NC) and contained 27,
27, and 2% iron by weight , respectively. The crocidolite sample used had a mean length
of 10 µm and mean width of 0.27 µm , determined by scanning electron microscopy.
Sodium bicarbonate and the reagents to prepare phosphate buffered saline (PBS)
were obtained from Fisher Scientific (Pittsburgh, PA). A custom preparation of Ham's F12 tissue culture medium (free of added iron salts) and 0.5% trypsin (with 0.2% EDTA)
were obtained from Invitrogen (Carlsbad, CA). Gentamicin (50 mg/ml) was obtained
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from Biowhittaker Inc. (Walkersville, MD) . Fetal bovine serum (FBS) was obtained
from Hyclone Laboratories Inc. (Logan, UT).
Desferrioxamine B (DF), phytic acid (PA), titanium dioxide (TiO 2), cytochalasin
Band D (CB and CD), and epidermal growth factor (EGF) were purchased from SigmaAldrich (St. Louis, MO). Biotin-N-hydroxysuccinimide ester, Biotin-X-NHS, and
horseradish peroxidase-conjugated streptavidin were purchased from Calbiochem (San
Diego, CA). Antibodies were purchased from either Santa Cruz Biotechnology Inc.
(Santa Cruz, CA) or Cell Signaling Technology (Beverly, MA). Protein NG plus-a garose
beads were purchased from Santa Cruz Biotechnology, Inc . (Santa Cruz, CA). Antimouse and anti-rabbit enzyme-conjugated secondary antibodies were purchased from
Jackson Immunoresearch Laboratories Inc. (West Grove, PA) . Chemiluminescent
Western blotting detection reagent (ECL) was purchased from Amersham Biosciences,
Inc. (Piscataway, NJ), and X-ray film was purchased from Kodak (Kodak, Rochester,
NY). Radio label [y-32 P] ATP was purchased from ICN Biomedicals Inc. (Irvine, CA). All
remaining reagents were purchased in the highest purity possible.
Cell Culture. A human lung epithelial cell line, A549, with characteristics of
alveolar epithelial type II cells, was used for the majority of these studies . The A549 cells
(ATCC CCL185) were purchased from American Type Culture Collection (Rockville,
MD). The cells were cultured as previously described by Chao et al. (12). Briefly, A549
cells were cultivated in complete growth medium in a Forma Model 315B water-jacked
incubator (Forma Scientific, Marietta, OH) at 37 ± 1°C in an atmosphere of 5 ± 0.5%
CO 2 and 95% humidity. Complete growth medium was composed of iron-free Ham's
Fl 2 cell culture medium, 50 µg/ml gentamicin, 10% FBS, and 1.176 g NaHCO 3/l
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medium to obtain a final pH of7.4. For maintenance of stock cultures, cells were
dislodged with 0.5% trypsin and 0.2% EDTA before reaching confluence, resuspended in
complete growth medium, and plated.
A human pleural mesosothelial cell line immortalized by transformation with
SV40 T antigen (MET5A) was kindly provided from Dr. Brenda Gerwin and Dr. Curtis
Harris (Laboratory of Human Carcinogenesis, NCI, Bethesda, MD). The cells were
cultured as previously described by Pache et al. (5), with some modifications . Briefly,
MET5A cells were maintained in a complete iron-free Ham's F12 cell culture medium
containing hydrocortisone (100 ng/ml), insulin (2.5 µg!ml) and transferrin (2.5 µg/ml).
For maintenance of stock cultures, cells were dislodged with 0.5% trypsin and 0.2%
EDT A before reaching confluence, resuspended in a complete growth medium, and
plated.
Primary cultures of human small airway epithelial cells (SAEC) (Clonetics,
Walkersville, MA) from the distal airspace were used for some experiments . The SAEC
cells were cultured in small airway growth medium (Clonetics, Walkersville, MA), as
directed by the manufacturer.

Preparation of Asbestos for Treatment of Cells. Cells were treated with
crocidolite, amosite, or chrysotile . Fibers were suspended in sterile 14 mM NaHCO 3 (pH
7.4) at a concentration of 1 mg/ml immediately before treatment of cells, vortexed for l
min, and diluted to the appropriate concentration with the growth medium.

Treatment of Cells with Asbestos Fibers. The cells were cultured until ~ 75%
confluent, rinsed with PBS, then dislodged with trypsin-EDT A and plated at a density of
20,000 cells/cm 2 . Twenty-four hours prior to and during treatment, cells were cultured in
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0.5% FBS, referred to as serum-deprived . After the indicated treatment time intervals ,
the medium, containing the fibers that were not associated with cells and/or
phagocytized, was removed . The cells were rinsed with ice-cold PBS, pH 7.4, and
dislodged with 0.5% trypsin. The cell pellets were stored at - 80°C.

Lysate Preparation and Western Blotting. Cell lysates were prepared for
Western blotting, as described by Simeonova et al. (13), with some modifications.
Briefly, after treatments, cells were lysed in RIP A buffer containing protease inhibitors
(30 µl /ml aprotonin, 4 µg/ml leupeptin, 4 µg/ml soybean trypsin inhibitor, 0.1 M PMSF,
and 1 µM benzamidine), and tyrosine phosphatase inhibitor (1 mM sodium
orthovanadate). Lysates were cleared by centrifugation at 15,000 x g for 30 min at 4°C,
and the protein concentrations were determined by the Bradford method. Lysates were
then subjected to electrophoresis in 8-12 % SDS-PAGE, and transferred to polyvinyl
difluorid e (PVDF) membranes . The membranes were incubated with blocking solut ion
(5% milk) to reduce nonspecific binding. Then , the appropriate primary antibodies
(1:1000 dilution) were applied (I hat room temperature or overnight at 4°C), followed by
incubation with the secondary enzyme -conjugated antibodies (1: 10,000 dilution) for 2 h
at room temperature . Immune complexes were visualized on the PVDF membranes by
ECL, and detected by exposure to X-ray film, as directed by the manufacturer.

Immunoprecipitation and In Vitro Kinase Assay. Immunoprecipitation was
performed , as described by Simeonova et al. (13), with some modifications . Briefly, after
treatments, cells were washed with ice-cold PBS, and lysed with 1.0 ml of solubilization
buffer [1% Triton, 5 mM EDTA, 150 mM NaCl, 50 mM NaF, 10 mM Tris/HCl, pH 7.6)
containing protease inhibitors and tyrosine phosphatase inhibitor, as described in Lysate
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Preparation and Western Blotting. Lysates were cleared by centrifugation at 15,000 x g
for 30 min at 4°C, and the protein concentrations were determined by the Bradford
method. Lysates were then immunoprecipitated by overnight incubation with the
indicated antibody at 4°C, followed by protein A/G plus-agarose precipitation for 2 h.
The beads bearing the immunoprecipitates were washed three times with ice-cold
solubilization buffer for the in vitro kinase assay.

In vitro kinase phosphorylation assays were performed, as described by Zanella et
al. (6), with some modifications. Briefly, the imrnunoprecipitated proteins were washed
twice with the kinase buffer [20 mM HEPES, pH 7.5, 0.015% Triton, 0.1 mM EDTA]
and resuspended in the kinase reaction buffer [0.15 mM ATP, 30 mM MgCh] containing
poly (Glu, Tyr, 4: 1) (Sigma-Aldrich, St. Louis, MO) as an artificial substrate, and
32

radio label [y- P] ATP ( 10 µCi/ml) . The kinase reactions were carried out for 10 min at
30°C, and were terminated by adding 4 x SDS sample buffer. Samples were separated on
10% SDS-PAGE . Gels were dried and exposed to X-ray film at -80°C for
autoradiography.

Biotin Labeling of EGFR. Methods for biotin labeling of cell surface receptors
have been described by Ravid et al. (4). Briefly, 24 h prior to treatment cells were
cultured in 0.5% FBS . The cells were then incubated with 0.5 mg/ml Biotin X-NHS for
45 min at 4°C. Washing the cells with ice-cold PBS containing 15 mM glycine ended
biotinylation of primary amine groups of proteins. Then, after washing with room
temperature PBS the cells were treated as indicated . Following treatment, proteins were
lysed and immunoprecipitated, as described in Immunoprecipitation and In Vitro Kinase
Assay. Protein labeling was detected with horseradish peroxidase-conjugated

streptavidin, a biotin-binding protein with four high affinity-binding sites. Immune
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complexes were visualized on the PVDF membranes with ECL, and detected by exposure
to X-ray film, as directed by the manufacturer.
Incubation of Cells with DF-Crocidolite, Phytic Acid or Cytochalasins. In
some experiments, the role of iron was examined by treating the cells with crocidolite
from which the redox active iron (bioavailable iron) had been removed with
desferrioxamine B (DF-crocidolite). DF-crocidolite was prepared, as previously
described (14) . This treatment removed approximately 8% of the total iron from the
fibers and the majority of the bioavailable iron. The fibers were resuspended immediately
before use, as described in Treatment of Cells with Asbestos Fibers. In some
experiments, another iron chelator, phytic acid (PA), was added to the A549 cells 1 h
before treatment. Crocidolite fibers were then added to PA-containing culture medium on
the cells .
To inhibit endocytosis of fibers, 1 h prior to and during treatment, cells were
cultured in the presence of 5 µglml cytochalasin B or D.
Statistical Analysis. The results are expressed as the mean± SE. A student 's t
test was used to assess the significance of differences between two groups . Probability
values < 0.05 were considered significant. The in vitro kinase assay and Western blotting
experiments were repeated two and three times , respectively .

RESULTS
Effects of EGF on EGFR Phosphorylation. To investigate if A549 cells,
originally obtained from an alveolar carcinoma, respond to EGF as do normal cells,

serum-deprived A549 cells were treated with EGF at 100 ng/ml. Consistent with
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previous findings by Goldkorn et al. (15) the addition of EGF stimulated a rapid
autophosphorylation of the EGFR, as measured by Western blotting analysis using
antibodies recognizing either the total EGFR or the EGFR phosphorylated on Y1068 and
Yl 173 (Fig . 3-lA). The tyrosine phosphorylation peaked between 15 and 30 min after the
addition of EGF and then rapidly declined . We also investigated the effects of EGF on
kinase activation of the EGFR by means of a traditional in vitro kinase assay using [y-32 P]
ATP and the universal protein tyrosine kinase substrate poly (Glu, Tyr, 4: 1) (Fig. 3-lB) .
Consistent with Western blotting results, EGF markedly increased the phosphorylation
level of both the receptor (data not shown) and the substrate above that of the control,
untreated cells. A 4.7-fold increase was observed with the peak response after 30 min.
Taken together, these results demonstrated that A549 cells showed normal responses to
EGF.

Effects of Three Types of Asbestos Fibers on EGFR Phosphorylation. We
comparatively examined the ability of three types of asbestos fibers to modulate the
phosphorylation state of YI 068 and Yl 173 in EGFR . In contrast to the positive control ,
all three types of asbestos fibers significantly decreased constitutive phosphorylation of
Y1068 and Yl 173 (Fig. 3-2). The amount of decrease in phosphorylation observed after
crocidolite, amosite or chrysotile treatment appeared to be directly related not only to the
percentage of iron by weight present in the different forms, 27, 27, and 2%, respectively,
but also to the amount of iron mobilized from these fibers (16).
Since Zanella et al. (6) have shown that asbestos induces EGFR phosphorylation
rather than dephosphorylation in RPM cells, we analyzed if different types ofF12 media
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Fig. 3-1. Effects of EGF on EGFR Phosphorylation. Serum-deprived A549 cells
were incubated with or without 100 ng/ml EGF for the indicated time intervals. A,
cellular lysates were subjected to Western blotting analysis, as described under Materials
and Methods. Phosphorylation of Yl 068 and Yl 173 of the EGFR was detected using the
phospho-specific antibodies. EGFR levels were detected using an anti-EGFR antibody
(the upper and lower bands represent phosphorylated and not phosphorylated EGFR
forms, respectively). B, one mg protein aliquots from untreated or EGF-treated A549
cells were subjected to immunoprecipitation with anti-EGFR, and to traditional in vitro
kinase assays with the substrate poly (Glu, Tyr, 4: 1), as described under Materials and
Methods. The in vitro kinase assay and Western blotting experiments were repeated two
and three times, respectively, and the representative autoradiograms are shown. The
optical densities (OD) of the bands were quantified. The results are shown as the mean±
SE, and are expressed as fold increase relative to the untreated control. Error bars
represent the SE. * P <0.05 compared with control, untreated groups.
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Fig. 3-2. Effects of Three Types of Asbestos Fibers on EGFR Phosphorylation.
2
Serum-deprived A549 cells were treated with 6 µg/cm crocidolite (CRO), amosite (A) or
chrysotile (short and intermediate range; CSR and CIR, respectively) for 24 h, or with
100 ng/ml EGF for 15 min (positive control). Cellular lysates were subjected to Western
blotting analysis, as described under Materials and Methods. Phosphorylation of Y 1068
and Yl 173 of the EGFR was detected using the indicated antibodies. EGFR levels were
detected using an anti-EGFR antibody (the upper and lower bands represent
phosphorylated and not phosphorylated EGFR forms, respectively). The two upper bands
in EGFR are due to low percentage SOS-PAGE gels. Data presented is representative of
three separate experiments.

(Kaighn's modification, with or without Fe) or serum (dialyzed or normal FBS) could
change the effects of asbestos on EGFR in A549 cells. We observed that neither medium
nor serum had an impact on asbestos-induced EGFR dephosphorylation in A549 cells
(data not shown).

Effects of Crocidolite on ErbB2/HER2 Phosphorylation. Since HER2, one of
the 4 members of the ErbB receptor family, acts synergistically with EGFR and both are
thought to interact with each other by transphosphorylation via heterodimer formation,
we examined the effect of asbestos fibers on HER2 membrane receptors (Fig. 3-3).
Consistent with the results with EGFR, crocidolite treatment decreased the constitutive
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Fig. 3-3. Effects of Crocidolite on ErbB2/HER2 Phosphorylation. Time
2
Dependence. Serum-deprived A549 cells were treated with 6 µg/cm crocidolit e (CRO)
for the indicated time intervals. Cellular lysates were subjected to Western blotting
analysis, as described under Materials and Methods. Phosphorylation of Y1248 and Y877
of the ErbB2/HER2 was detected using the indicated antibodies. ErbB2/HER2 levels
were detected using an anti-ErbB2 antibody. Data presented is representative of three
separate experiments .

phosphorylation levels on Y877, the site involved in regulation of HER2 biological
activity, and Y1248, one of the major autophosphorylation sites that couples HER2 to the
Ras-Raf-MAP kinase signal transduction pathway . Interestingly , we also observed a
minor , time-dependent decrease in the total level of HER2 protein, suggesting that HER2
inactivation could be coupled to its degradation. Overall, it appears that crocidolite
treatment is able to affect not only EGFR, but also other members of the ErbB family of
receptor tyrosine kinases .

Effects of Crocidolite on EGFR Activation. Time and Dose Dependences.
Because asbestos decreased the constitutive EGFR phosphorylation, it was necessary to
determine whether this phenomenon was time and/or concentration dependent. For the
remainder of the study only crocidolite was used. EGFR dephosphorylation after
crocidolite treatment occurred within the first 3 h with a peak response at 24 h (almost
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total disappearance of phosphorylation bands) (Fig. 3-4A). Furthermore, we also
investigated the ability of crocidolite to modulate the in vitro kinase activity of the EGFR
(Fig. 3-4B). Crocidolite treatment decreased the phosphorylation of the receptor (data not
shown) and decreased the phosphorylation activity of EGFR on the substrate below that
of the control, untreated cells.
Others have observed that Ti0 2 particles do not cause cell apoptosis (17) or a
change in mitochondrial membrane potential (~\Jim)(18, 19). Thus, we also investigated
the effects of Ti0 2 on the EGFR activity . In contrast to crocidolite, Ti0 2 had no effect on
the EGFR phosphorylation state (Fig. 3-4C) . This is consistent with previous findings
that Ti0 2 did not affect the cells.
Treatment of cells with three different concentrations of crocidolite resulted in a
dose-dependent decrease in the EGFR phosphorylation (Fig . 3-5A). A strong association
between crocidolite concentration and the receptor dephosphorylation was observed .
Importantly, MET5A and normal human small airway epithelial cells showed similar
responses to crocidolite, suggesting that the responses observed in A549 cells were
representative of transformed and normal human cells (Fig. 3-5B and C). Next, we
investigated if exposure of A549 cells to three concentrations of crocidolite for 24 h
could affect the in vitro kinase activity of the EGFR (Fig. 3-5D). In comparison to
untreated control cells exhibiting constitutive levels of phosphorylation, crocidolite
treatment (1.5, 3, 6 µg/cm 2) decreased the phosphorylation activity of EGFR on the
substrate below that of the control by approximately two- to fourfold in a dose-dependent
manner.
Interestingly, we also found that the inhibitory effects of asbestos were not
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Fig. 3-4. Effects of Crocidolite and TiO 2 on EGFR Activation. Time Dependence.
2
A, serum-deprived A549 cells were incubated with 6 µglcm crocidolite (CRO) for the
indicated time intervals, or with 100 ng/ml EGF for 15 min (positive control). Cellular
lysates were subjected to Western blotting analysis, as described under Materials and
Methods. Phosphorylation of Y1068 and Yl 173 of the EGFR was detected using the
indicated antibodies. EGFR levels were detected using an anti-EGFR antibody (the upper
and lower bands represent phosphorylated and not phosphorylated EGFR forms,
respectively). B, one mg protein aliquots from untreated or crocidolite-treated A549 cells
were subjected to imrnunoprecipitation with anti-EGFR, and to traditional in vitro kinase
assays with the substrate poly (Glu, Tyr, 4: 1), as described under Materials and Methods .
2
C, serum-deprived A549 cells were incubated with 6 µglcm crocidolite (CRO) or TiO 2
for the indicated time intervals. Cellular lysates were subjected to Western blotting
analysis, as described above. The in vitro kinase assay and Western blotting experiments
were repeated two and three times, respectively, and representative autoradiograms are
shown. The optical densities (OD) of the bands were quantified. The results are shown as
the mean± SE, and are expressed as fold increase relative to the untreated control. Error
bars represent the SE. * P <0.05 compared with control, untreated groups.
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Fig. 3-5. Effects of Crocidolite on EGFR Activation. Dose Dependence . A , serumdeprived A549 cells were incubated with three different concentrations of crocidolite
2
(CRO) (1.5, 3, 6 µg/cm ) for 24 h. Cellular lysates were subjected to Western blotting
analysis, as described under Materials and Methods. Phosphorylation of Y 1068 and
Yl 173 of the EGFR was detected using the indicated antibodies. EGFR levels were
detected using an anti-EGFR antibody (the upper and lower bands represent
phosphorylated and not phosphorylated EGFR forms, respectively). B, MET5A cells
2
were incubated with or without crocidolite (1.5, 3, 6 µg/cm ) for 24 h, and cellular lysates
were subjected to Western blotting analysis, as described above. C, SAEC cells were
2
incubated with or without crocidolite (3 and 6 µg/cm ) for 24 h, and cellular lysates were
subjected to Western blotting analysis, as described above . D, one mg protein aliquot s
from untreated or crocidolite-treated A549 cells were subjected to immunoprecipit ation
with anti-EGFR , and to traditional in vitro kinase assays with the substrate poly (Glu,
Tyr, 4: 1), as described under Materials and Methods. The in vitro kinase assay and
Western blotting experiments were repeated two and three times, respectively , and
representative autoradiograms are shown. The optical densities (OD) of the bands were
quantified . The results are shown as the mean± SE, and are expressed as fold increase
relative to the untreated control. Error bars represent the SE. * P <0.05 compar ed with
control , untreated groups.
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suppressed by actinomycin D or cycloheximide, indicating that the effects of
crocidolite were independent of transcription and translation (data not shown).

Effects of Crocidolite on EGFR Degradation. Since lysosomal targeting of
EGFR has been shown to be independent of the tyrosine kinase activity (20), we
investigated if asbestos-induced EGFR dephosphorylation was coupled to receptor
degradation. Phosphorylation of Yl045 in the EGFR creates a major docking site for cCbl, which in turn enables receptor ubiquitination and degradation. Thus, we analyzed
the phosphorylation status ofY1045 and the levels ofEGFR before and after asbestos
treatment. Additionally, since Zhuang et al. (21) showed that oxidative stress led to a
caspase-mediated EGFR degradation during the early phase of cell death, we followed
the fate of the surface EGFR more specifically with Biotin-X-NHS . Consistent with
observations by Ravid et al. (4), 15-min EGF treatment resulted in significant Y1045
phosphorylation (Fig. 3-6A) . Also, in the presence of 100 ng/ml EGF for 9 h, the levels of
biotinylated EGFR wer e dramatically decreased (Fig. 3-6B) . In contrast , crocidolite
exposure from 3-24 h resulted in negligible Y1045 phosphorylation with no apparent
decrease in biotinylated EGFR (Fig. 3-6A and B). Thus, crocidolite treatment did not lead
to EGFR degradation.

Effects of Cytochalasins, Desferrioxamine B, and Phytic Acid on Crocidolitelnduced EGFR Inactivation. To determine whether asbestos-induced EGFR
inactivation required the uptake of fibers, we blocked actin polymerization, which
prevents endocytosis, with cytochalasins. As shown in Fig. 3-7A, cytochalasin B or D
(CB and CD), alone, had negligible effect on EGFR phosphorylation. However, treatment
of A549 cells with crocidolite in the presence of cytochalasin B or D (CB/CRO or
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Fig. 3-6. Effects of Crocidolite on EGFR Degradation. A, serum-deprived A549
2
cells were incubated with or without 6 µg/cm crocidolite (CRO) for the indicated time
intervals, or with I 00 ng/ml EGF for 15 min (positive control). Cellular lysates were
subjected to Western blotting analysis, as described under Materials and Methods .
Phosphorylation of YI 045 of the EGFR was detected using the indicated antibody. B, cell
surface proteins of serum-deprived A549 cells were biotinylated, followed by incubation
2
with 6 µg/cm crocidolite for the indicated time intervals, or with 100 ng/ml EGF for 9 h
(positive control) . Biotin protein labeling was detected with horseradish peroxidaseconjugated streptavidin , as described under Materials and Methods. The experiments
were repeated three times and representative autoradiograms are shown.
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Fig. 3-7. Effects of Cytochalasins, Desferrioxamine Band Phytic Acid on
Crocidolite-Induced EGFR Inactivation. A, serum-deprived A549 cells were pretreated
with or without 5 µg/ml cytochalasin D or B (CD and CB) for I h, followed by
incubation with 6 µg/cm 2 crocidolite for 24 h (CRO). Cellular lysates were subjected to
Western blotting analysis, as described under Materials and Methods. Phosphorylation of
Y1068 and YI 173 of the EGFR was detected using phospho-specific antibodies. EGFR
levels were detected using an anti-EGFR antibody (the upper and lower bands represent
phosphorylated and not phosphorylated EGFR forms, respectively). B, serum-deprived
A549 cells were incubated with three different concentrations of crocidolite (CRO), 1.5,
2
3, 6 µg/cm , for 24 h, or fibers from which the redox active iron had been removed with
desferrioxamine B (DF-CRO). Cellular lysates were subjected to Western blotting
analysis, as described above . C, one mg protein aliquots from crocidolite- or DF-CROtreated A549 cells were subjected to immunoprecipitation with anti-EGFR, and to
traditional in vitro kinase assays with the substrate poly (Glu , Tyr, 4: 1), as describ ed
under Materials and Methods. D, serum-deprived A549 cells were treated with 6 µglcm 2
DF-CRO for 24 h, or the cells were pretreated with or without 500 µM phytic acid (PA)
for l h, followed by incubation with 6 µg!cm 2 crocidolite for 24 h (P AJCRO). Cellular
lysates were subjected to Western blotting analysis, as described above. The in vitro
kinase assay and Western blotting experiments were repeated two and three times,
respectively, and representative autoradiograms are shown. The optical densities (OD) of
the bands were quantified. The results are shown as the mean ± SE, and are expr essed as
fold increase relative to the untreated control. Error bars represent the SE. * P <0.05
compared with 6 µg/cm 2 crocidolite.
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CD/CRO) resulted in a considerable inhibition of EGFR dephosphorylation. Notably,
cytochalasin D treatment resulted in a much higher inhibition of receptor
dephosphorylation than respective treatment with cytochalasin B. Nevertheless, cotreatment of A549 cells with fibers and either cytochalasin did not result in a full
recovery of receptor phosphorylation levels. Taken together, the results presented here
strongly suggest that fiber endocytosis is an important step for EGFR dephosphorylation.
We have previously shown that the pretreatment of asbestos fibers (22) and coal fly ash
(23) with an iron chelator desferrioxamine B (DF-crocidolite and -CF A, respectively)
greatly reduced the ability of these particulates to exert their pathological effects. To
determine if iron associated with crocidolite was involved in EGFR inactivation, serumdeprived A549 cells were treated with three concentrations of DF-crocidolite (1.5, 3, 6
µg/cm 2) for 24 h. Iron removal from crocidolite was able to greatly inhibit the amount of
the EGFR dephosphorylation, compared with that seen with fibers not treated with a
chelator (Fig. 3-7B). Furthermore, we also investigated the ability ofDF-crocidolite to
modulate the in vitro kinase activity of the EGFR (Fig . 3-7 C). Consistent with the
Western blotting analysis , incubation of cells with DF-crocidolite radically inhibited
dephosphorylation levels of the receptor (data not shown) and inhibited EGFR
phosphorylation activity on the substrate compared with that seen with fibers not treated
with a chelator. Further evidence implying an important role for iron in the EGFR
inactivation was that fibers incubated with PA, another iron chelator, also decreased the
levels of receptor dephosphorylation (Fig. 3-7D). PA alone had no effect on the EGFR
phosphorylation level. Noteworthy is the fact that OF-pretreated fibers inhibited
crocidolite-induced EGFR inactivation to a much greater extent than crocidolite co-
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incubated with PA. Taken together, the correlation between iron removal from
crocidolite fibers and inhibition of receptor dephosphorylation clearly supports the
involvement of iron in the inactivation of EGFR.

DISCUSSION
In the present study we observed that asbestos treatment of human lung epithelial
and pleural mesothelial cells resulted in EGFR dephosphorylation and inactivation. This
phenomenon may represent a potentially important mechanism by which relevant human
lung and pleural target cells respond to asbestos fibers. The results presented here
strongly suggest that the fibers must be internalized for the EGFR to be inactivated, and
that the iron associated with fibers was directly or indirectly responsible for some of this
effect. The inhibitory effects of asbestos were not suppressed by actinomycin D or
cycloheximide, showing that these phenomena were independent of transcription and
translation. We also found that treatment with crocidolite decreased the phosphorylatio n
levels of the HER2 two major tyrosine residues. Based on these results we conclude that
asbestos fibers modulate not only EGFR, but also other members of the ErbB family of
receptor tyrosine kinases, suggesting a global membrane receptor inactivation rather than
a unique inhibition of EGFR . Understanding the role of ErbB receptor family inactivation
in asbestos-induced multiple effects on target cells may provide new insights into the
process of carcinogenesis.
The interaction between asbestos and EGFR has mostly been investigated in
rodent cells and rodents. Two research groups have observed that asbestos treatment of
RPM cells induced EGFR phosphorylation (2, 6, 11). Increases in EGFR mRNA and
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protein synthesis have also been noted (2). Additionally, Manning et al. (8) have
observed EGFR-mediated proto-oncogene expression and cell proliferation in transgenic
mice and murine C 10 cells. The results presented here support other studies in the
literature showing differences between rodent and human tissue in terms of resistance to
genotoxicity and/or cytotoxicity by asbestos (24) .
On the other hand, the interaction between asbestos and EGFR has not been
thoroughly explored in humans. The studies were limited to microscopic work, as
reported by Pache et al. (5). Interestingly, they observed that MET5A cells showed
patterns of aggregation and increases in EGFR protein on the surface of cells
phagocytizing long asbestos fibers ( 2'.60 µm), while no changes were observed in A549
cells. Our observations reported herein are inconsistent with that work. A comparative
examination of human A549 and MET5A cells showed that patterns of EGFR
dephosphoryl ation caused by asbestos were similar. In both cell lines the amount of
decrease in phosphorylation correlated with dose and time .
A549 cells are one of the three most common cultured human lung epithelial cell
lines being used as a tissue culture model of lung epithelial cells in research . However,
since A549 cells were originally obtained from an alveolar carcinoma, there is concern
that they may not be a faithful representation of normal cells . However, in the studies
presented here, A549 cells responded in the same way to crocidolite as normal human
small airway epithelial cells (SAEC). We have previously shown that A549 cells
responded similarly to particles (glutathione efflux, ferritin induction) when compared
with SAEC and that the responses were not an artifact of a single cell type (25). This was
complemented by our findings that crocidolite treatment of both SAEC and A549 cells
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resulted in a decrease in the EGFR phosphorylation levels in a dose-dependent manner.
We conclude that the responses observed in A549 cells are representative of not only
mesothelial and epithelial cells, but also of normal and transformed human lung cells.
We have also observed that in contrast to EGF-treated cells, EGFR remains at
the plasma membrane throughout the 24-h exposure time to crocidolite, suggesting that
receptor dephosphorylation is not coupled to its degradation . Since there are several
pathways leading to receptor degradation, i.e. lysosome or proteasome, we used two
distinctive approaches to investigate this. We observed that asbestos failed to initiate not
only ubiquitin-mediated lysosomal targeting but also alternative mechanisms ofreceptor
downregulation .
Inert particulates, such as TiO 2 or glass beads, do not cause any pathological
effects in either mesothelial (26, 27) or epithelial cells (17-19). Consistent with that, we
observed that significant decreases in the EGFR phosphorylation levels occurred with
crocidolite, but not with TiO 2 . The fact that iron on the asbestos fibers appears to be
related to EGFR dephosphorylation may explain the differences observed between TiO 2
and asbestos.
There is significant evidence demonstrating that iron was mobilized
intracellularly from asbestos fibers and was responsible for 0 2 consumption, lipid
peroxidation, and DNA oxidation. It has been proposed that iron mobilized from asbestos
into a low-molecular-weight fraction led to pathological phenomena, including cancer.
DF and PA, which bind tightly to all of the iron coordination sites making it inert, can
prevent iron-derived reactive oxygen species production within cells. We found that iron
chelators had inhibitory effects on crocidolite-induced EGFR dephosphorylation.
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Noteworthy is the fact that the long-term removal of bioavailable iron from crocidolite
by DF prior to exposure to cultured cells inhibited EGFR inactivation to a much greater
extent than fibers co-incubated with PA. We also observed that the amount of EGFR
dephosphorylation in A549 cells by two types of asbestos, crocidolite and amosite , was
significantly greater than that by the third type, chrysotile, either short or intermediate
length fibers. Also, direct comparison of short and intermediate length chrysotile fibers
revealed that intermediate fibers seemed to be somewhat more toxic to A549 cells than
short fibers, which could be due to differences in the fiber dimensions and/or iron
bioavailability. Most importantly, the observed effects of crocidolite, amosite and
chrysotile on the EGFR phosphorylation state appeared to be related to the amount of
iron mobilized from these fibers (16). Thus, there appeared to be a correlation between
iron mobilization from asbestos and the degree of EGFR dephosphorylation.
Since the EGFR is an integral membrane protein with crucial domains on both
sides of the plasma membrane, we examined whether the process of fiber endocytosis
was necessary for its inactivation. We observed that the endocytosis inhibitor
cytochalasin considerably inhibited EGFR dephosphorylation . Interestingly , analysis of
the results revealed that CD treatment resulted in a much greater inhibition of receptor
dephosphorylation caused by crocidolite than respective treatment with CB. This
phenomenon could be simply explained by the fact that CD is a much more potent
inhibitor of actin polymerization than CB. Endocytosis is also important for other
asbestos-mediated effects in lung epithelial cells (14) and mesothelial cells (28, 29). We
have previously observed that endocytosis of crocidolite in A549 cells was required for
iron mobilization (14) . This uncontrolled entry of iron may represent "iron overload" in
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cells endocytizing the fibers, which could be responsible for many asbestos-dependent
biological effects . These observations, taken together, suggest that the effects of asbestos
on EGFR are mediated intracellularly, not extracellularly.
It is apparent that iron associated with crocidolite was required, at least in part, for

EGFR dephosphorylation. The primary mechanism by which iron from asbestos fibers
leads to receptor inactivation is not yet clear. Iron can act as both an oxidant and a
reductant, directly or indirectly through generation of ROS. Kamata et al. (30) have
shown that redox-sensitive cellular processes could inactivate EGFR. Direct treatm ent of
cells with

H202

activates , rather than inactivates, EGFR activity (4). These treatments

could have had extracellular, as well as intracellular effects and certainly would expose
cells to much higher levels of H20 2 then would ever be generated by asbestos. Also, as
discussed earlier, it appears that asbestos exerts its effects intracellularly (14) . It is
possible that asbestos may be activating protein phosphatases that dephosphorylat e and
inactivate the EGFR. Zhuang et al. (21) have recently observed that exposure of human
keratinocytes to singlet oxygen resulted in rapid decreases in EGFR phosphoryl ation
through activation of protein phosphatases .
Activation of EGFR and its signaling is believed to be an important contributor to
the growth and survival of cells in a variety of conditions . Thus, the dephosphorylation
and inactivation of EGFR observed after asbestos treatment may be one step in the
pathway leading to apoptosis . Stimuli other than asbestos have also been shown to inhibit
EGFR phosphorylation resulting in G 1 arrest, up-regulation of p27 (9), and subsequent
apoptosis (10). Recent evidence strongly suggests a relationship between inactivation of
EGFR-associated survival pathways and stimulation of the stress-activated protein
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kinases in terms of a balance between cell death and proliferation. The emerging role
of EGFR inactivation in relevant human lung and pleural target cells may be of critical
importance in the process of apoptosis. Several groups have independently provided
strong evidence that asbestos triggers apoptosis in mesothelial (2, 26, 27, 31-33) and
epithelial cells (34), including A549 cells (17-19). Apoptosis represents an important
mechanism critical for elimination of defective cells without stimulating an inflammatory
response. However, extensive cell death due to apoptosis can lead to compensatory
proliferation of surrounding cells. If these replicating cells have already sustained critical
mutations, then replication could promote formation of a tumor. We are currently
investigating the signaling events responsible for asbestos-induced EGFR
dephosphorylation and apoptosis in human lung epithelial cells.
In conclusion, we observed that crocidolite treatment of A549, MET5A and
SAEC cells resulted in EGFR dephosphorylation and inactivation. This effect appeared to
be mediated, at least in part, by the presence of bioavailable iron, and appeared to be
mediated intracellularly . Inactivation of EGFR may be an important step in the path way
leading to apoptosis. Elucidation of molecular mechanisms underlying asbestos-indu ced
DNA damage and apoptosis may lead to a better understanding of asbestos-related
pulmonary toxicity .
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CHAPTER4
CROCIDOLITE IRON INITIATES APOPTOSIS IN HUMAN LUNG
EPITHELIAL CELLS VIA P38 MAPK-MEDIATED
PATHWAYS

ABSTRACT
Despite intensive investigation the mechanism of asbestos-induced
carcinogenicity is not well understood . We have previously observed that asbestos
induced dephosphorylation and inactivation of epidermal growth factor receptor (EGFR)
in relevant human lung target cells . Here, we investigated the role of signal transduction
events in crocidolite-induced apoptosis of human lung epithelial (A549) cells and normal
human small airway epithelial (SAEC) cells . We observed that exposure of A549 and
SAEC cells to crocidolite, but not inert TiO 2 , led to a significant time- (15 min to 24 h)
and dose- (1.5, 3, and 6 µg/cm 2) dependent inactivation of the main EGFR signaling
pathways, including A.kt and extracellular signal-regulated kinase 1/2 (ERKl/2)
pathways. Crocidolite also initiated apoptosis via pathways involving activation of p38
mitogen-activated protein kinase (MAPK), caspase -3 and -9, and cleavage of poly(ADP ribose) polymerase (PARP) . Prevention of these effects with an iron chelator or
endocytosis inhibitors strongly suggests that iron mobilized from fibers inside the cells
initiates the observed events . Inhibition of p38 MAPK with SB203580 prevented
inactivation of EGFR, inactivation ofEGFR-associated survival pathways, and initiation
of apoptosis. Taken together, it appears that iron-dependent p38 MAPK activation plays a
central role in crocidolite-induced apoptosis of human lung epithelial cells via inhibition
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ofERKl/2

and Akt survival pathways and concurrent activation of caspase-3 and -9.

Asbestos-induced apoptosis in target human lung cells may account for some of the
pulmonary toxicity of the fibers.

INTRODUCTION
Although asbestos was recognized to be a human carcinogen in the late 1950s, the
mechanism by which it causes mesothelioma of the pleura and bronchogenic carcinoma
of the lung is still not well understood. It has been shown that iron from asbestos
catalyzes the generation ofreactive oxygen species (ROS), such as superoxide radical
(02--) and hydroxyl radical (·OH) (1). In addition, iron has been shown to be responsible
for 0 2 consumption (2), DNA oxidation (3), lipid peroxidation (4), human lung epithelial
cell apoptosis (5), and potentially cancer. There is also significant evidence suggesting
that iron from sources other than asbestos may cause human cancer.

It is now believed that the imbalance between apoptosis and proliferation plays a
critical role in the process of carcinogenesis . Apoptosis is a physiological process critical
for organ development, tissue homeostasis and elimination of defective cells without
stimulating an inflammatory response. It might also play an important role in the
development of diseases (6, 7), such as cancer, by leading to compensatory proliferation
of cells with damaged DNA (8). Studies by others have demonstrated asbestos-induced
apoptosis in both rodent (9-13) and human (5, 9, 14, 15) lung cells. The mechanism of
asbestos-induced apoptosis in the lung cells is not entirely known. Studies in rodent cells
and rodents provided some insights into the signal transduction pathways involved in
asbestos-induced apoptosis. Mossman and coworkers have shown that in addition to
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mitochondrial-regulated

pathways (11), apoptosis was associated with signaling

through epidermal growth factor receptor (EGFR) and subsequent activation of the
extracellular-regulated

protein kinase (ERKl/2) cascades (12). Additionally, Swain et al.

(16) have suggested an important role for p38 mitogen-activated protein kinase (MAPK)
in asbestos-induced cytotoxicity in rat pleural mesothelial (RPM) cells . Since some
differences were reported in the way rodent and human cells responded to asbestos fibers
(unpublished observations), it is of great importance to examine and compare the
asbestos-induced signaling events in human lung epithelial cells . Kamp and coworkers
have established that asbestos induces apoptosis in human lung epithelial cells (5, 14, 15).

It was proposed that apoptosis resulted from mitochondrial dysfunction and was, in part,
due to iron-derived ROS . Nevertheless, the signaling cascades involved in asbestosinduced apoptosis in human cells have not been thoroughly explored.
The ErbB receptor superfamily, of which EGFR is an important member , is one
of the major systems participating in the transduction of signals through the highly
conserved MAPK cascade and the phosphatidylinositol 3-kinase (PIJK/Akt) pathway . It
has been shown that EGF-like growth factors activate both pathways (17) , while
inhibition of the ErbB receptors suppress them (18) . MAPKs phosphorylate specific
serines and threonines of target protein substrates and regulate cellular activities ranging
from gene expression, mitosis, movement, metabolism, and programmed death. It is now
recognized that the MAPK superfamily is made up of three main and distinct signaling
pathways: the ER.Ks, the c-Jun N-terminal kinases or stress-activated protein kinases
(JNK/SAPK), and the p38 family ofkinases. The ER.Ks are strongly activated by growth
factors, whereas various cell stresses, such as hyperosmotic shock, metabolic stress or
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protein synthesis inhibitors, UV radiation, heat shock, cytokines, and ischemia can
activate JNK/SAPKs and p38 MAPK (19). Signaling by PI3K/Akt is believed to be one
of the pivotal pathways regulating cell growth and proliferation. Phosphorylation of Akt
substrates results in antiapoptotic effects (20). It seems as if the dynamic balance among
PI3K/ Akt, ERKl/2 and JNK/SAPK and p38 pathways may govern the ability of cells to
survive or undergo apoptosis (21). It has been observed that blockade of PI3K/Akt and
ERKl/2 pathways with concurrent activation of the p38 pathway suppressed cell survival
and subsequently stimulated apoptosis in HeLa cells (22). As reviewed earlier, several
independent research groups have provided evidence for the involvement of some
signaling cascades in apoptosis of rodent cells following asbestos exposure (11, 12, 16).
However, the effects of asbestos on the control and coordination of the signal
transduction pathways in human lung cells have not been investigated.
We have recently observed that treatment of human lung epithelial (A549) ,
normal human small airway epithelial (SAEC) and human pleural mesothelial (MET5A)
cells with asbestos resulted in dephosphorylation and subsequent inactivation of EGFR
(unpublished observations) . This led us to investigate the effects of asbestos on EGFRdependent and -independent signal transduction pathways in A549 cells and SAEC cells.
Our findings strongly suggest a central role for the upstream activation of p38 MAPK in
altering the fine balance between cell survival and death . Most importantly, iron
mobilized from fibers inside the cells appeared to initiate the activation of p38 MAPK
leading to apoptosis. We speculate that apoptosis may be an important response of
relevant human lung target cells and that asbestos pathogenesis may result from altered
apoptotic mechanisms.
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MATERIALS AND METHODS
Asbestos and Reagents. Crocidolite was obtained from Dr. Richard Griesemer,

National Institute for Environmental Health Sciences/National Toxicology Program
(Research Triangle Park, NC) and contained 27% iron by weight. The crocidolite sample
used had a mean length of 10 µm and mean width of 0.27 µm, determined by scanning
electron microscopy.
Sodium bicarbonate and the reagents to prepare phosphate buffered saline (PBS)
were obtained from Fisher Scientific (Pittsburgh, PA). A custom preparation of Ham ' s F12 tissue culture medium (free of added iron salts) and 0.5% trypsin (with 0.2% EDTA)
were obtained from Invitrogen (Carlsbad, CA). Gentamicin (50 mg/ml) was obtained
from Biowhittaker Inc. (Walkersville, MD). Fetal bovine serum (FBS) was obtained from
Hyclone Laboratories Inc. (Logan, UT) .
Desferrioxamine B, titanium dioxide (TiO 2), cytochalasin B and D, and epidermal
growth factor were purchased from Sigma-Aldrich (St. Louis, MO). Antibodies were
purchased from either Santa Cruz Biotechnology Inc. (Santa Cruz, CA) or Cell Signaling
Technology (Beverly, MA). Anti-mouse and anti-rabbit enzyme-conjugated secondary
antibodies were purchased from Jackson Immunoresearch Laboratories Inc. (West Grove,
PA). Chemiluminescent Western blotting detection reagent (ECL) was purchased from
Amersham Biosciences, Inc . (Piscataway, NJ), and x-ray film was purchased from Kodak
(Kodak, Rochester, NY). All remaining reagents were purchased in the highest purity
possible.
Cell Culture. A human lung epithelial cell line, A549, with characteristics of

alveolar epithelial type II cells, was used for the majority of these studies. The A549 cells
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(ATCC CCL185) were purchased from American Type Culture Collection (Rockville,
MD) . A549 cells were cultivated in complete growth medium in a Forma Model 315B
water-jacked incubator (Forma Scientific, Marietta, OH) at 37 ± l °C in an atmosphere of
5 ± 0.5% CO2 and 95% humidity. Complete growth medium was composed of iron-free
Ham's Fl2 cell culture medium, 50 µg/ml gentamicin, 10% FBS, and 1.176 g NaHCO 3/l
medium to obtain a final pH of7.4. For maintenance of stock cultures, cells were
dislodged with 0.5% trypsin and 0.2% EDT A before reaching confluence, resuspended in
complete growth medium, and plated.
Primary cultures of normal human small airway epithelial cells (SAEC)
(Clonetics, Walkersville, MA) from the distal airspace were used for some experiments.
The SAEC cells were cultured in small airway growth medium (SAGM) (Clonetics,
Walkersville , MA), as directed by the manufacturer.

Treatment of Cells. The cells were cultured until ~ 75% confluent, rinsed with
PBS, then dislodged with trypsin-EDT A and plated at a density of 20,000 cells/cm 2.
Twenty-four h prior to and during treatment, cells were cultured in 0.5% FBS, referred to
as serum-deprived . Cells were treated with crocidolite fibers . Fibers were suspended in
sterile 14 mM NaHCO 3 (pH 7.4) at a concentration of l mg/ml immediately before
treatment of cells, vortexed for l min, and diluted to the appropriate concentration with
the growth medium . After the indicated treatment time intervals, the medium, containing
the fibers that were not associated with cells and/or phagocytized, was removed. The
cells were rinsed with ice-cold PBS, pH 7.4, and dislodged with 0.5% trypsin. The cell
pellets were stored at - 80 °C until use.
In some experiments, the role of iron was examined by treating the cells with
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crocidolite from which the redox active iron (bioavailable iron) had been removed with
desferrioxamine B (DF-crocidolite). DF-crocidolite was prepared, as previously
described (23). This treatment removed approximately 8% of the total iron from the
fibers and the majority of the bioavailable iron . The fibers were resuspended immediately
before use, as described above.

In some experiments, the cells were treated with various inhibitors . To inhibit
EGFR kinase activity the cells were treated withquinazoline AG-1478 for 2 h. To inhibit
endocytosis of fibers or to inhibit p38 MAPK, the cells were treated for 1 h prior to and
during treatment with 5 µglml cytochalasin Band Dor 20 µM SB203580, respectively.
The stock solutions of the inhibitors were made in dimethyl sulfoxide and diluted to the
appropriate concentrations in culture medium.

Lysate Preparation and Western Blotting. Cell lysates were prepared for
Western blotting, as described by Simeonova et al. (24), with some modifications .
Briefly, after treatments, cells were lysed in RIP A buffer containing protease inhibitors
(30 µI/ml aprotonin, 4 µglml leupeptin, 4 µglml soybean trypsin inhibitor, 0.1 M PMSF,
and 1 µM benzamidine) , and tyrosine phosphatase inhibitor (1 mM sodium
orthovanadate). Lysates were cleared by centrifugation at 15,000 x g for 30 min at 4°C,
and the protein concentrations were determined by the Bradford method. Lysates were
then subjected to electrophoresis in 8-12 % SDS-PAGE, and transferred to polyvinyl
difluoride (PVDF) membranes. The membranes were incubated with blocking solution
(5% milk) to reduce nonspecific binding. Then, the appropriate primary antibodies
(1: 1000 dilution) were applied (1 hat room temperature or overnight at 4 °C), followed by
incubation with the secondary enzyme-conjugated antibodies (1: 10,000 dilution) for 2 h
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at room temperature. Immune complexes were visualized on the PVDF membranes by
ECL, and detected by exposure to X-ray film, as directed by the manufacturer .

RESULTS

Effects of Crocidolite on Akt and ERKl/2 Pathways. We have previously
observed that exposure of A549 cells to crocidolite caused dose- and time-dependent
dephosphorylation and inactivation of EGFR (unpublished observations) . Since major
downstream signaling routes of the EGFR are thought to proceed via Ras-Raf-MAPkinase and PI3K/Akt pathways (20), we investigated whether one or more of these
kinases were affected in response to crocidolite in A549 cells . We employed Western
blotting analysis using specific phospho-antibodies to look at phosphorylation levels of
Raf, MEK 1,2, ERKl/2, p90Rsk, Elk-1 (ERKl/2 signaling pathway) , as well as PTEN,
PDKl , Akt, FKHR, GSK-3,B(Akt signaling pathway) (Fig . 4-lA and B) . Crocidolite
tre atment blocked phosphorylation of all these prot eins, except for PTEN , which
remained phosphorylated throughout the treatment. PTEN , a dual-specificity phosphatase
that is activated upon dephosphorylation, has been shown to be a major negative
regulator of the PI3K/ Akt pathway . The effects were observed within the first 3 h with a
dramatic decr ease in phosphorylation after 24 h. We observed that crocidolite caused
inactivation of the Akt pathway independently of PTEN activation . In contrast to
ERKl /2, the long -term dephosphorylation of Akt was accompanied by its subsequent
degradation (Fig. 4-1 C).
Epidermal growth factor (EGF) was used as a positive control in these
experiments. Consistent with findings by others (17), treatment with EGF induced time-
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Fig. 4-1. Effects of Crocidolite and EGFR Kinase Inhibitor, AG 1478, on Akt and
2
ERKl/2 Pathways. Serum-deprived A549 cells were treated with 6 µg/cm crocidolite
(CRO), 100 ng/ml EGF for the indicated time intervals, or with 1 µM EGFR kinase
inhibitor AG 1478 for 2 h; Cellular lysates were subjected to Western blotting analysis, as
described under Materials and Methods. Phosphorylation of EGFR, PTEN, PD Kl, Akt,
FKHR, GSK-3,B, Raf, MEKl/2, ERKl/2, p90Rsk and Elk-1 was detected using the
indicated phospho-antibodies specific to activated forms of proteins. Akt and ERK 1/2
protein contents were analyzed with antibodies to Akt or ERK 1/2. Data presented is
representative of three separate experiments.
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dependent increases in the phosphorylation level of Akt and ERK.1/2 (Fig . 4-lD) . The
level of total ERK 1/2 and Akt proteins remained unchanged during this treatment.
A highly selective inhibitor of the EGFR tyrosine kinase activity, tyrphostin AG1478, was used to determine whether EGFR inhibition affected the phosphorylation states
of Akt and ERK.1/2 in these cells. Consistent with observations by others (25), exposure
to AG 1478 resulted in a blockage of constitutive EGFR phosphorylation, as well as
MAPK and Akt phosphorylation (Fig. 4-1£). Taken together, crocidolite treatment of
A549 cells resulted in an efficient blockade of the main EGFR signal transduction
pathways, including the MAPK and Akt pathways .

Effects of Crocidolite on Akt and ERKl/2 Phosphorylation States in Human
Lung Epithelial A549 and Normal Human Small Airway Epithelial SAEC Cells. We
have previously observed that crocidolite treatment of A549 cells or SAEC cells resulted
in very similar responses (26). Our recent data showed that crocidolite treatment of both
A549 and normal SAEC cells resulted in a reduction in the EGFR phosphorylation levels
in a dose-dependent manner. Consistent with these findings, crocidolite treatment led to a
dose-dependent blockage of phosphorylation ofERKl/2 and Akt in both A549 and
SAEC cells (Fig . 4-2A and B). It has been previously observed that Ti0 2 particles do not
cause EGFR dephosphorylation (unpublished observations), human lung cell death (15),
or a change in mitochondrial membrane potential (~ lJ'm) (5, 14). Thus, we also
investigated the effects of Ti0 2 on the ERK.1/2 and Akt phosphorylation states (Fig . 42C). Ti0 2 did not affect protein expression, nor did it change the phosphorylation states
of ERK.1/2 or Akt. This is consistent with previous findings that Ti0 2 did not affect the
cells.
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Fig. 4-2. Effects of Crocidolite and TiO 2 on Akt and ERKI/2 Phosphorylation
States in Human Lung Epithelial Cells. A and B, serum-deprived A549 and SAEC cells
2
2
were incubated with or without 1.5, 3 and 6 µg/cm , or 3 and 6 µg/cm crocidolite
(CRO), respectively, for 24 h. C, serum-deprived A549 cells were incubated with 6
2
µg/cm crocidolite (CRO) or TiO 2 for the indicated time intervals; Cellular lysates were
subjected to Western blotting analysis, as described under Materials and Methods.
Phosphorylation of Akt and ERKI/2 was determined using antibodies specific to
activated Akt and ERKI/2 . Data presented is representative of three separate
experiments.
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Effects of Crocidolite on Total Cellular Threonine, Serine and Tyrosine
Phosphorylation States. Because crocidolite blocked the phosphorylation of proteins in
two major survival pathways, it was of great interest to determine whether the observed
phenomena were representative of effects on proteins throughout the cell. Thus, we next
examined effects of crocidolite on the phosphorylation status of proteins in the whole cell
lysates. Exposure of A549 cells to crocidolite caused a significant, time-dependent
blockage of most cellularphosphothreonine, phosphoserine and phosphotyrosine below
the control, untreated cells (Fig . 4-3). Dephosphorylation was observed as early as 0.25 h
with dramatic effects after 24 h. Noteworthy is the fact that the phosphorylation levels of
some proteins remained unchanged and the levels of some proteins were increased above
those of the control.

Effects of Crocidolite on p38 MAPK. Time and Dose Dependences. It has been
shown that p38 MAPK is strongly activated by a variety of environmental stresses (19).
Additionally, asbestos was shown to activate p38 MAPK in rat pleural mesothelial cells
(16). Since some differences were reported in the way rodent and human cells responded
to asbestos fibers (unpublished observations), we examined whether crocidolite treatment
affected the phosphorylation state of p38 MAPK in A549 cells , and whether p38 MAPK
could play a role in the crocidolite-induced injury in human lung epithelial cells . When
cells were treated with crocidolite, a transient increase in p38 MAPK phosphorylation
was observed, as measured by Western blotting with an antibody specific to activated p38
MAPK (Fig. 4-4A). Levels of p38 MAPK phosphorylation began to increase at 0.25 h
and reached a peak at 12 h. In addition, treatment of cells with three different
concentrations of crocidolite (1.5, 3 and 6 µg/cm 2) resulted in a dose-
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Fig. 4-3 . Effects of Crocidolite on Total Cellular Phosphothreonine,
Phosphoserine and Phosphotyrosine Levels . Serum-deprived A549 cells were incubated
2
with 6 µg /cm crocidolite (CRO) for the indicated time intervals. Cellular lysates were
subjected to Western blotting analysis, as described under Materials and Methods .
Phosphorylation of the total cellular phosphothreonine (A) , phosphoserine (B) and
phosphotyrosine (C) levels were determined using the indicated phospho-specific
antibodies. Data presented is representative of three separate experiments.
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Fig. 4-4. Effects of Crocidolite on p38 MAPK. Time and Dose Dependences .
2
Serum-deprived A549 cells were incubated with 6 µg/cm crocidolite (CRO) for the
indicated time intervals (A), or with three concentrations of crocidolite (CRO) (1.5, 3, 6
2
µg /cm ) for 24 h (B). Cellular lysates were subjected to Western blotting analysis, as
described under Materials and Methods . Phosphorylation of p38 MAPK was determined
with antibody specific to activated p38 MAPK . Total p38 MAPK protein content was
analyzed with an antibody to p38 MAPK. Data presented is representative of three
separate experiments.

dependent increase in the p38 MAPK phosphorylation state (Fig. 4-4B). Regardless of
treatment, the level of p3 8 MAPK protein remained unchanged.

104

Effects of Crocidolite on Caspases and Poly(ADP-ribose) Polymerase.
Since we observed that crocidolite treatment resulted in inactivation of some of the most
important survival pathways, i.e. PI3K/Akt and ERK.1/2 pathways, we examined whether
crocidolite induced apoptosis under these conditions . Caspase-3 and -9, which are
important mediators of apoptosis, are synthesized as inactive precursors that are
proteolytically cleaved to generate active enzymes . Crocidolite, but not inert particulate
Ti 0 2, caused a time- and dose-dependent cleavage of caspase-3 and -9 (Fig. 4-5), as has
been observed by others (11, 14, 15, 27). Poly(ADP-ribose) polymerase (P ARP) is one of
the main cleavage targets of caspase-3 . Consistent with caspase-3 activation , crocidolite
treatment induced cleavage of P ARP (Fig. 4-5). Taken together, these results support the
involvement of bioavailable iron from endocytized crocidolite fibers in the activation of
p38 MAPK and subsequent apoptosis.

Effect of p38 MAPK Inhibitor on Crocidolite-Induced Events. The data to this
point suggested a role for p38 MAPK in crocidolite-induced cellular events . However , it
did not address the question of where in this series of events p38 MAPK functioned. To
determine whether p38 MAPK was involved in the initiation of dephosphorylation of
kinases in survival cascades , a pyridylimidazole derivative SB203580, a potent inhibitor
of p38 MAPK activity , was used before treatment of cells with crocidolite. We observed
that blockade of p38 MAPK activity abolished crocidolite-induced EGFR , Akt and
ERK.l/2 dephosphorylation (Fig . 4-6A).
The above results indicated a central role for the upstream activation of p38
MAPK in altering the survival pathways. We further examined the role of p38 MAPK
activation in crocidolite-induced apoptosis . One-hour pretreatment with SB203580
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Fig. 4-5. Effects of Crocidolite and TiO 2 on Caspases and Poly(ADP-ribose)
2
Polymerase States. Serum-deprived A549 cells were incubated with 6 µg/cm crocidolite
(CRO) (A and C) or TiO2 for the indicated time intervals (C), or with three concentrations
2
of crocidolite (1.5, 3, 6 µg/cm ) for 24 h (B). Cellular lysates were subjected to Western
blotting analysis, as described under Materials and Methods. Activation of caspase-3 and
-9 was determined with anti-caspase-3 or -9 antibodies. PARP cleavage analysis was
performed with anti-PARP antibody. Data presented is representative of three separate
experiments.
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Fig. 4-6. Effects of p38 MAPK Inhibitor on Crocidolite-Induced Events. Serumdeprived A549 cells were pretreated with or without 20 µM p38 MAPK inhibitor,
SB203580, for 1 h (Control), followed by incubation with 6 µg/cm 2 crocidolite for 24 h
(p38 I/CRO). Cellular lysates were subjected to Western blotting analysis, as described
under Materials and Methods. A, phosphorylation of EGFR, Akt, ERKl/2 and p38
MAPK was determined using antibodies specific to activated Akt, ERKl/2 and p38
MAPK. EGFR protein content was analyzed with an antibody to EGFR (the upper and
lower bands represent phosphorylated and not phosphorylated EGFR forms,
respectively). B, activation of caspase-3 and -9 was determined with anti-caspase-3 or -9
antibodies. PARP cleavage analysis was performed with anti-PARP antibody. Data
presented is representative of three separate experiments.
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significantly blocked crocidolite-induced caspase-3 and -9 cleavage (Fig . 4-6B) .
Consistent with this result, SB203580 also inhibited cleavage of PARP . The inhibitor
itself had negligible effect on the levels of caspase-3, -9 and P ARP and the
phosphorylation states of the ERK.1/2, Akt and p38 MAPK.

Effects of Cytochalasins and Desferrioxamine on Crocidolite-lnduced Events.
To determine whether crocidolite-induced changes in signal transduction events required
the uptake of fibers and the intracellular release of iron, we blocked actin polymerization,
which prevents endocytosis, with cytochalasins. As shown in Fig. 4-7A, cytochalasin B or
D (CB or CD, respectively), alone, had negligible effect on the phosphorylation states of
the ERK.1/2, Akt and p38 kinases. However, treatment of A549 cells with crocidolite in
the presence of CB or CD resulted in a considerable blockage of the dephosphorylation
patterns . Notably , CD appeared to be a much more potent inhibitor than CB.
Previously we observed that pretreatment of asbestos fibers (3) or coal fly ash
(28) with an iron chelator desferrioxamine (DF) greatly reduced the ability of these
particulates to exert their biological effects . Consistent with that, we have recently shown
that DF pretreatment of crocidolite blocked crocidolite-induced EGFR dephosphorylation
and subsequent inactivation (unpublished observations) . Thus, we examined the role of
crocidolite-associated iron in the observed signaling events. When serum-deprived A549
cells were treated with three concentrations of DF-crocidolite (1.5, 3, 6 µg /cm 2) for 24 h,
we observed a significant dose-dependent inhibition of crocidolite-induced
dephosphorylation of Akt and ERK.1/2 (Fig. 4-7B). Additionally, chelation of iron from
crocidolite fibers was also able to greatly block the amount of p38 MAPK
phosphorylation, compared with that seen with unchelated fibers.

108

A

P-p38
Control

CRO

CD

CD/CRO

CB

CB/CRO

24 h

B
P-Akt

..

---.

.

~

f{IIIIIII!;.,

P-ERKl/2
P-p38
Control

1.5 Jig

3 Jig,
CRO 24 h

6 Jig

1.5 Jlg

3 Jlg

6 Jig

DF-CRO 24 h

Fig. 4-7. Effects of Cytochalasins and Desferrioxamine on Crocidolite-Induced
Events. A and C, serum-deprived A549 cells were pretreated with or without 5 µg/ml
cytochalasin D or B (CD and CB) for 1 h, followed by incubation with 6 µg/cm 2
crocidolite for 24 h (CD/CRO and CB/CRO). B and D, serum-deprived A549 cells were
2
incubated with three concentrations of crocidolite (CRO), 1.5, 3, 6 µg/cm , for 24 h, or
fibers from which the redox active iron had been removed with desferrioxamine B (DFCRO). Cellular lysates were subjected to Western blotting analysis, as described under
Materials and Methods. Phosphorylation of Akt, ERK.1/2 and p38 MAPK was
determined using antibodies specific to activated Akt, ERK.1/2 and p38 MAPK.
Activation of caspase-3 and -9 was determined with anti-caspase-3 or -9 antibodies.
PARP cleavage analysis was performed with anti-PARP antibody. Data presented is
representative of three separate experiments.
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Consistent with the above results, pretreatment of A549 cells with cytochalasins
as well as removal of the majority of the bioavailable iron from fibers with OF,
significantly blocked activation of caspase-3 and-9, and cleavage of PARP (Fig . 4-7C
and D).

DISCUSSION
We have previously reported that exposure of relevant human lung target cells to
asbestos fibers resulted in dephosphorylation and subsequent inactivation of EGFR
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(unpublished observations) . Results presented here strongly suggest that p38 MAPK
controls the molecular survival/death switch that directs the cells away from
survival/proliferation to apoptosis . Most importantly, we observed that iron mobilized
from fibers inside the cells initiated, in part if not entirely, the observed phenomena .
The effects of asbestos on signal transduction pathways controlling survival and
apoptosis have only been investigated in rodent cells (27, 29-31) and rodents (32, 33).
Two research groups have observed that asbestos treatment of RPM cells induced EGFR
phosphorylation (12, 34). Additionally, Jimenez et al. (29) have observed that asbestosinduced RPM cell apoptosis was associated with activation of ERK, but not JNK/SAPK
pathways. The results reported herein reveal not only important species differences but
also the complexity and diversity of regulatory mechanisms in asbestos-induced
apoptosis .
EGFR is an important signal transducer that activates many signaling pathways ,
e.g. PI3K/ Akt and ERKl/2 pathways, resulting in increased proliferation and cell
survival, as well as inhibition of apoptosis . We observed that in contrast to EGF
treatment, crocidolite asbestos, but not inert particulates (TiO 2), caused a dose- and timedependent inactivation of EGFR-associated survival pathways, including Akt and
ERK l/ 2 pathways. We observed that the Akt phosphorylation state was not influenced by
PTEN, a dual specificity phosphatase, even though PTEN has been shown to negatively
regulate the PI3K/ Akt pathway. This suggests an alternative mechanism of Akt
dephosphorylation after crocidolite exposure, which has also been observed in some
malignant tumors (35). Treatment of A549 cells with crocidolite also caused a timedependent decrease in cellular phosphothreonine, phosphoserine and phosphotyrosine,
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suggesting major protein dephosphorylation events rather than unique effects of
crocidolite on Akt and ERK.1/2 pathways. Additionally, a potent EGFR inhibitor,
AG1478, inhibited activation of Akt and ERK.1/2, as has also been observed by others
(25). Consistent with our previous observation that EGFR was inhibited by crocidolite
treatment, it appears that the observed inactivation of the survival pathways depended on
the inhibition of EGFR kinase activity.
We have previously observed that A549 cells showed similar responses to
particles (glutathione efflux, ferritin induction) as normal human small airway epithelial
(SAEC) cells and that the responses were not an artifact of the tumor origin of the A549
cells (26) . Our recent findings showed that crocidolite treatment of A549, MET5A and
SAEC cells resulted in EGFR dephosphorylation in a dose-dependent manner
(unpublished observations). Consistent with that, in the studies presented here, we
observed that exposure of A549 and SAEC cells to crocidolite led to interruption of Akt
and ERK 1/2 signaling. We conclude that the responses observed in A549 cells are
representative of human lung epithelial cells in these respects.
Independent studies have provided strong evidence that asbestos triggers
apoptosis in both rodent (9-13) and human (5, 9, 14, 15) cells. It appears that asbestos induced apoptosis in lung target cells may account for the pathogenic effects of the fibers.
However, in contrast to rodent cells , the signaling cascades involved in asbestos-induced
apoptosis in human cells have not yet been identified . Our results presented here showed
that exposure to crocidolite, but not inert particulates (TiO 2), resulted in a dose- and timedependent activation of the pro-apoptotic p38 MAPK, and subsequently initiation of
apoptosis in human lung epithelial cells. The characteristic features of apoptosis provided

112
by our studies include a dose- and time-dependent activation of caspase-3, -9, and
subsequent cleavage of PARP. The observed degradation of the survival protein Akt may
also accelerate apoptosis , as was reported by others (36). Interestingly, a potent inhibitor
of p38 MAPK activity, SB203580, was able to prevent not only activation of caspases
and cleavage of PARP, but also inactivation ofEGFR and survival pathways. Thus, it
appears that p38 MAPK plays a central role in crocidolite-induced apoptosis in A549
cells. Stimuli other than asbestos, i.e. nitric oxide (36), arsenite (37), phorbol esters (38),
have also been shown to induce apoptosis in a p38 MAPK-dependent manner. The
precise mechanism by which p38 MAPK leads to apoptosis is unclear. It has been
proposed that activated p38 MAPK may facilitate cytochrome c release and subsequent
activation of caspases (39). It has also been suggested that protein phosphatases may be
direct targets for p38 MAPK-mediated phosphorylation. Westermarck et al. (40) have
observed that activation of p38 MAPK resulted in increased protein phosphatase activity
that directly inhibited ERKl/2 and MEKl,2 phosphorylation. Additionally, activated
phosphatases may regulate the alternative splicing of specific apoptotic factors, i.e.
caspase 9 and Bcl-x (41) .
Cytochalasins, the endocytosis inhibitors , blocked asbestos -induced injury to
mesothelial and lung epithelial cells (9). Also, it has been observed that iron mobilized
from asbestos fibers was responsible for DNA oxidation (42) and mitochondrial
dysfunction (5, 14, 15). Consistent with that, our results presented here showed that
decreasing fiber uptake or removal of bioavailable iron with DF prevented the observed
cellular events and apoptosis. Cytochalasin D appeared to be a more potent inhibitor of
actin polymerization than cytochalasin B. This phenomenon could be simply explained
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by the fact that CD is a much more potent inhibitor of actin polymerization than CB.
Taken together, we propose a model of crocidolite-induced apoptosis in human
lung epithelial cells involving p38 MAPK control of cell survival/apoptosis (Fig. 4-8).
This may involve iron-dependent p38 MAPK-mediated activation of protein
phosphatases and subsequent dephosphorylation of EGFR and EGFR-associated survival
pathways (Akt and ERKl/2), as well as, activation of apoptotic pathways (casapase-3,
-9). Apoptosis may represent an important mechanism of eliminating cells that have
asbestos-induced DNA alterations during the process of carcinogenesis. Even though
apoptosis is responsible for normal tissue homeostasis, it might also play an important
role in the development of diseases, such as cancer (7). It has been observed that
excessive death of epithelial cells, which appeared to overwhelm the clearing mechanism,
led to persistent inflammation (6). There is a body of evidence suggesting a direct
correlation between alveolar epithelial cell apoptosis and lung pathological disorders
(43) . In addition, some reports suggest that a primary increase in apoptosis can stimulate
compensatory proliferation (8) . Increased cell proliferation without a compensatory
increase in apoptosis may be associated with tumor promotion and progression. Finally,
we speculate that some cells may bypass the protective mechanism of apoptosis , i.e.
resistance to and/or defects in apoptosis, which could allow the abnormal survival of the
target lung cells with asbestos-induced mutations. Development of malignant tumors in
humans is a multi-staged process, which may require 40 years or more after initial
exposure to asbestos. During this time, DNA damage, mutagenesis, apoptosis and
compensatory cell proliferation may represent successive and/or coexistent phenomena.

In summary, our results strongly suggest that iron mobilized from fibers inside
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Fig. 4-8 . Model of Crocidolite-Induced p38 MAPK-Mediated Apoptosis in
Human Lung Epithelial Cells. The signaling events appear to be initiated by iron
mobilized from crocidolite fibers inside the cells . Additionally, p38 MAPK appears to
control the molecular survival/death switch that directs the cells away from
survival/proliferation to apoptosis. This may involve p38 MAPK-mediated activation of
protein phosphatases and subsequently dephosphorylation of EGFR and EGFRassociated survival pathways (Akt and ERKl/2), as well as, p38 MAPK-mediated
activation of apoptotic pathways (casapase-3, -9, PARP). Decreasing fiber uptake
(cytochalasins) and removal of bioavailable iron with iron chelator desferrioxamine
prevented the observed cellular events and apoptosis.

human lung epithelial cells initiates the crocidolite-induced signaling events preventing
survival, but activating apoptosis pathways. It is of great importance to understand the
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molecular events by which iron initiates activation of p38 MAPK and by which p38
MAPK induces the subsequent cellular responses. Better understanding of the molecular
mechanisms underlying the balance between proliferation and apoptosis in relevant
human lung target cells may promote more effective strategies for asbestos-related
pulmonary toxicity.
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CHAPTER 5
P38 MA.PK-DEPENDENT ACTIVATION OF PROTEIN
PHOSPHATASES REGULATES ASBESTOS-INDUCED
APOPTOSIS IN HUMAN LUNG
EPITHELIAL CELLS

ABSTRACT
Despite intensive investigation the mechanism of asbestos-induced
carcinogenicity is unknown. We have previously demonstrated that asbestos induced
dephosphorylation and inactivation of epidermal growth factor receptor (EGFR) . Also,
we found that p38 mitogen-activated protein kinase (MA.PK) played a central role in
asbestos-induced apoptosis in human lung epithelial (A549) cells via inhibition of
extracellular signal-regulated kinase (ERKl/2) and Akt survival pathways, and
concurrent activation of caspase-3 and -9. Exposure of A549 cells to asbestos also caused
a significant, time-dependent blockage of cellular phosphoserine and phosphotyrosine
below the control, untreated cells. Here, we investigated the role of protein phosphatases
(PPases) in asbestos-induced apoptosis in A549 cells. Treatment with okadaic acid (OA)
(200 nM), an inhibitor of protein phosphatase 2A (PP2A) and protein phosphatase -I
(PPl) at the concentrations used, but not with sodium orthovanadate (VA) (50 µM), an
inhibitor of protein tyrosine phosphatases, protected the cells from asbestos-induced
apoptosis. Importantly, inhibition of p38 MA.PK by SB203580 (20 µM), selective
decreases in fiber uptake and removal of the redox active iron from the fibers resulted in
significant attenuation of asbestos-induced dephosphorylation of cellular proteins. Our
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results demonstrate that p38 MAPK, through a serine/threonine phosphatasemediated mechanism, regulates asbestos-induced apoptosis in human lung epithelial
cells. We speculate that the intracellular imbalance between protein phosphorylation and
dephosphorylation caused by asbestos is a critical determinant of both cell survival and
death .

INTRODUCTION
Asbestos is a naturally occurring mineral that has been used for centuries because
of its unique physical and chemical properties, including durability, tensile strength, and
heat resistance. However, it was recognized to be a human carcinogen in the late 1950s,
which led to a complete cessation of the use of asbestos-containing commercial products.

It has been demonstrated that exposure to asbestos increases the risk of both malignant
(1) and nonmalignant (2) diseases. Even though it is not clear how asbestos exerts these
effects , the carcinogenicity of asbestos has been related to some of its physical properties ,
such as size and durability of fibers (3). The most carcinogenic forms of asbestos contain
as much as 27% iron by weight (4, 5). It has been proposed that iron from asbestos
catalyzes the generation of reactive oxygen species (ROS), such as superoxide radical
(0 2 -- ) and hydroxyl radical (·OH) (3, 6). In addition , iron has been shown to be

responsible for 0 2 consumption (7), induction of DNA single-strand breaks (8), lipid
peroxidation (9), and potentially cancer. There is also significant evidence suggesting that
iron from other sources besides asbestos may cause human cancer (10, 11).
Protein phosphorylation and dephosphorylation are central mechanisms that
mediate signal transduction events that control a variety of cellular processes ( 12, 13).
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Target proteins are phosphorylated at specific serine, threonine, or tyrosine residues
by protein kinases and the phosphate group is removed by the action of specific protein
phosphatases (PPases). Over 98% of all phosphorylations occur on serine and threonine
residues, whereas the remaining less than 2% affects tyrosine (14). PPases are present in
all eukaryotic cells and regulate numerous cellular processes including cell cycle
progression, transcriptional regulation, cell growth, differentiation and apoptosis .
Abnormal PPase activity has been implicated in diseases such as diabetes, inflammation,
and cancer (15, 16). There are two main classes of PPases according to their substrate
specificity , i.e. protein tyrosine phosphatases (PTPases) and protein serine/threonine
phosphatases (PS Pases), which remove phosphate from proteins containing
phosphotyrosine or phosphoserine /phosphothreonine , respectively (17). Interestingly,
PTPase family includes both tyrosine-specific and dual specificity phosphatases
(DSPases) that remove phosphate from proteins containing all three phosphoamino acid
residues . Biochemical studies have shown that PTPases and DSPases share a common
catalytic mechanism (18). PSPases are usually classified into type l(PPl) or type 2 (PP2),
depending on their substrate specificity and sensitivity to inhibitors . Type 2 phosphatases
are subdivided into three major groups; PP2A , calcium-dependent calcineurin PP2B and
magnesium-dependent PP2C (19) .
Okadaic acid (OA) has been shown to be a potent inhibitor of protein phosphat ase
1 (IC50 = 10 - 15 nM) and protein phosphatase 2A (IC 50 = 0.1 nM) (20). Because of its
very hydrophobic structure OA has been extensively used as a protein phosphatase
inhibitor in intact cells (21 ). It is now apparent that OA is an extremely valuable tool
useful to test the physiological role of protein phosphorylation and to study protein
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phosphatases in cell extracts as well as intact cells. Although OA induces apoptosis in
some cell lines (22, 23), inhibition of apoptosis by this agent has also been reported (2426).
Vanadate (VA) and its analogues have been widely used as inhibitors of PTPases
by mimicking the phosphorous group of phosphotyrosine (27). As a result a general
increase in cellular protein tyrosine phosphorylation has been observed (28), which in
tum led to activation of a variety of signaling pathways (29, 30). VA has also been used
as an inhibitor of DSPases. VA is known to prevent apoptosis in some cell lines (31-36)
but has been found in other studies to potentiate growth inhibition and apoptosis (34, 37).
Yang et al. (33) showed that VA prevented cell detachment, greatly enhanced cell
viability and blocked apoptosis of endothelial cells. They demonstrated that addition of
VA at low concentration (up to 50 µM) was protective, while higher concentrations did
not enhance cell survival. Prolonged incubation with higher concentrations of VA (>50
µM) with intact cells in culture appears to be toxic.

We have recently observed that asbestos induced dephosphorylation and
inactivation of epidermal growth factor receptor (EGFR) (see Chapter 3). Further, we
found that asbestos induced apoptosis in human lung epithelial (A549) cells in a p38
mitogen-activated protein kinase (MAPK)-dependent manner via inhibition of
extracellular signal-regulated kinase 1/2 (ERKl/2) and Akt survival pathways , and
concurrent activation of caspase-3 and -9 (see Chapter 4). Exposure of A549 cells to
asbestos also caused a significant, time-dependent blockage of cellular phosphoserine and
phosphotyrosine below the control, untreated cells. Phosphorylation and
dephosphorylation of proteins mediate signal transduction events that control a multitude
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of cellular processes that include metabolism, transport, cell division, differentiation
and development, learning and memory (12, 13). Recent studies strongly suggest that
PTPases as well as PSPases are essential components critically involved in the control of
apoptosis (33, 38). We therefore investigated the role of PPases in asbestos-induced
apoptosis in A549 cells, using OA and VA, specific inhibitors of PSPases and PTPases,
respectively. Our findings demonstrated that OA, but not VA, inhibited asbestos-induced
global cellular protein dephosphorylation and apoptosis . Importantly, iron mobilized
from fibers inside the cells and p38 MAPK activity appeared to be required for the
increased phosphatase activity following asbestos treatment. Taken together, our results
strongly suggest a critical role for PSPases in a p38 MAPK-mediated regulation of
asbestos-induced apoptosis in human lung epithelial cells.

MATERIALS AND METHODS
Asbestos and Reagents. Crocidolite was obtained from Dr. Richard Griesemer,
National Institute for Environmental Health Sciences/National Toxicology Program
(Research Triangle Park, NC) and contained 27% iron by weight. The crocidolite sample
used had a mean length of 10 µm and mean width of 0.27 µm, determined by scanning
electron microscopy .
Sodium bicarbonate and the reagents to prepare phosphate buffered saline (PBS)
were obtained from Fisher Scientific (Pittsburgh, PA). A custom preparation of Ham's F12 tissue culture medium (free of added iron salts) and 0.5% trypsin (with 0.2% EDTA)
were obtained from Invitrogen (Carlsbad, CA). Gentamicin (50 mg/ml) was obtained
from Biowhittaker Inc. (Walkersville, MD). Fetal bovine serum (FBS) was obtained from
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Hyclone Laboratories Inc. (Logan, UT).
Desferrioxamine Band cytochalasin D were purchased from Sigma-Aldrich (St.
Louis, MO). Antibodies were purchased from either Santa Cruz Biotechnology Inc.
(Santa Cruz, CA) or Cell Signaling Technology (Beverly, MA). Anti-mouse and antirabbit enzyme-conjugated secondary antibodies were purchased from Jackson
Immunoresearch Laboratories Inc. (West Grove, PA). Chemiluminescent Western
blotting detection reagent (ECL) was purchased from Amersham Biosciences, Inc.
(Piscataway, NJ), and x-ray film was purchased from Kodak (Kodak, Rochester, NY) .
All remaining reagents were purchased in the highest purity possible.

Cell Culture. A human lung epithelial cell line, A549, with characteristics of
alveolar epithelial type II cells, was used for the majority of these studies. The A549 cells
(ATCC CCL185) were purchased from American Type Culture Collection (Rockville,
MD). A549 cells were cultivated in complete growth medium in a Forrna Model 315B
water-jacked incubator (Forrna Scientific, Marietta, OH) at 37 ± 1°C in an atmosphere of
5 ± 0.5% CO 2 and 95% humidity. Complete growth medium was composed of iron-free
Ham's Fl2 cell culture medium, 50 µg/ml gentamicin, 10% FBS, and 1.176 g NaHCO)l
medium to obtain a final pH of 7.4. For maintenance of stock cultures, cells were
dislodged with 0.5% trypsin and 0.2% EDTA before reaching confluence, resuspended in
complete growth medium, and plated.

Treatment of Cells. The cells were cultured until~ 75% confluent, rinsed with
PBS, then dislodged with trypsin-EDT A and plated at a density of 20,000 cells/cm 2.
Twenty-four h prior to and during treatment, cells were cultured in 0.5% FBS, referred to
as serum-deprived. Cells were treated with crocidolite fibers. Fibers were suspended in
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sterile 14 mM NaHCO 3 (pH 7.4) at a concentration of 1 mg/ml immediately before
treatment of cells, vortexed for 1 min, and diluted to the appropriate concentration with
the growth medium. After the indicated treatment time intervals, the medium, containing
the fibers that were not associated with cells and/or phagocytized, was removed. The
cells were rinsed with ice-cold PBS, pH 7.4, and dislodged with 0.5% trypsin. The cell
pellets were stored at - 80 °C until use.

In some experiments , the role of iron was examined by treating the cells with
crocidolite from which the redox active iron (bioavailable iron) had been removed with
desferrioxamine B (DF-crocidolite). DF-crocidolite was prepared, as previously
described (39) . This treatment removed approximately 8% of the total iron from the
fibers and the majority of the bioavailable iron. The fibers were resuspended immediately
before use, as described above.
In some experiments, the cells were treated with various inhibitors. To inhibit
endocytosis of fibers or to inhibit p38 MAPK, the cells were treated for 1 h prior to and
during treatment with 5 µglml cytochalasin D or 20 µM SB203580, respectively . The
stock solutions of the inhibitors were made in dimethyl sulfoxide and diluted to the
appropriate concentrations in culture medium .

Lysate Preparation and Western Blotting. Cell lysates were prepared for
Western blotting, as described by Simeonova et al. (40), with some modifications .
Briefly, after treatments, cells were lysed in RIP A buffer containing protease inhibitors
(30 µI/ml aprotonin, 4 µg/ml leupeptin, 4 µg/ml soybean trypsin inhibitor, 0.1 M PMSF,
and 1 µM benzamidine), and tyrosine phosphatase inhibitor (1 mM sodium
orthovanadate ). Lysates were cleared by centrifugation at 15,000 x g for 30 min at 4°C,
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and the protein concentrations were determined by the Bradford method. Lysates
were then subjected to electrophoresis in 8-12 % SDS-PAGE, and transferred to
polyvinyl difluoride (PVDF) membranes. The membranes were incubated with blocking
solution (5% milk) to reduce nonspecific binding. Then, the appropriate primary
antibodies ( 1: 1000 dilution) were applied ( 1 h at room temperature or overnight at 4 °C),
followed by incubation with the secondary enzyme-conjugated antibodies (1: 10,000
dilution) for 2 hat room temperature. Immune complexes were visualized on the PVDF
membranes by ECL, and detected by exposure to X-ray film, as directed by the
manufacturer.

RESULTS
Effects of Cytochalasins, Desferrioxamine and p38 MAPK Inhibitor on
Crocidolite-lnduced Cellular Serine and Tyrosine Dephosphorylation. We have
previously observed that crocidolite blocked the phosphorylation of proteins in two major
survival pathways (see Chapter 3). We also demonstrated that the observed phenomena
were representative of effects on proteins throughout the cell. Exposure of A549 cells to
6 µg/cm 2 crocidolite caused a significant, time-dependent blockage of most cellular
phosphothreonine, phosphoserine and phosphotyrosine below the control, untreated cells.
To determine whether crocidolite -induced changes in the cellular protein phosphorylation
required the uptake of fibers and the intracellular release of iron, we blocked actin
polymerization, which prevented endocytosis, with cytochalasin D (CD). As shown in
Fig . 5-1, CD alone had little effect on the phosphorylation states of cellular serines and
tyrosines. However, treatment of A549 cells with crocidolite in the presence of CD
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Fig. 5-1. Effects of Cytochalasins, Desferrioxamine and p38 MAPK Inhibitor on
Crocidolite-Induced Cellular Serine and Tyrosine Dephosphorylation. Serum-deprived
2
A549 cells were incubated with medium (Control) or treated with either 6 µg/cm
crocidolite (CRO) or fibers from which the redox active iron had been removed with
desferrioxamine B (DF-CRO) for 24 h. Alternatively, cells were pretreated with 5 µglml
cytochalasin Dor 20 µM p38 MAPK inhibitor SB203580 for 1 h (Control), followed by
2
incubation with 6 µg/cm crocidolite for 24 h (CD/CRO and p38 1/CRO, respectively).
Cellular lysates were subjected to Western blotting analysis, as described under Materials
and Methods. Phosphorylation of the total cellular tyrosine (A) and serine (B) levels were
determined using phospho-specific antibodies . Data presented is representative of three
separate experiments.
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resulted in a considerable blockage of the dephosphorylation patterns .
We have previously observed that pretreatment of asbestos fibers (41) or coal fly
ash (42) with an iron chelator desferrioxamine (DF) greatly reduced the ability of these
particulates to exert their biological effects. Also, we have recently shown that DFcrocidolite significantly blocked the observed EGFR inactivation and apoptosis. Thus, we
examined the role of crocidolite-associated iron on total cellular serine and tyrosine
phosphorylation states. When serum-deprived A549 cells were treated with DFcrocidolite for 24 h, we observed a significant inhibition of crocidolite-induced cellular
phosphoserine and phosphotyrosine dephosphorylation (Fig. 5-1 ).
Although most cellular proteins were dephosphorylated upon crocidolite
treatment, noteworthy is the fact that the phosphorylation levels of some proteins
remained unchanged and the levels of some proteins were increased above those of the
control, i.e. p38 MAPK (data not shown). We have recently shown that p38 MAPK
activation played a central role in crocidolite -induced apoptosis of A549 cells via
inhibition of ERKl/2 and Akt survival pathways and concurrent activation of caspase-3
and -9 (see Chapter 3). Thus, we next examined whether p38 MAPK was involved in the
initiation of cellular protein dephosphorylation. A pyridylimidazole derivative SB203580,
a potent inhibitor of p38 MAPK activity, was used before treatment of cells with
crocidolite. We observed that blockade of p38 MAPK activity decreased crocidoliteinduced global phosphoserine and phosphotyrosine dephosphorylation (Fig. 5-1 ).

Effects of Okadaic Acid and Sodium Orthovanadate on Crocidolite-lnduced
Serine and Tyrosine Dephosphorylation. The data to this point suggested a role for
PPases in crocidolite-induced cellular events. However, it did not address the questions of
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what type of PPases played the most significant role and where in this series of events
PPases functioned. To determine whether PSPases and PTPases were involved in the
initiation of dephosphorylation of cellular proteins, OA, a potent inhibitor of protein
phosphatase l (IC 5o = l O - 15 nM) and protein phosphatase 2A (IC 50 = 0.1 nM) (20), or
VA (27), were used before treatment of cells with crocidolite. OA and VA were the most
effective at 200 nM and 50 µM, respectively (Fig. 5-2). It should be noted that
concentrations greater than 200 nM for OA appeared to be toxic to the A549 cells (data
not shown). We observed that blockade of PSPases activity with OA abolished not only
crocidolite-induced cellular phosphoserine dephosphorylation but also cellular
phosphotyrosine dephosphorylation. In contrast to OA, treatment with VA resulted in a
significant inhibition of crocidolite-induced phosphotyrosine dephosphorylation.
However, this treatment had no effect on the crocidolite-induced levels of cellular
phosphoserine .
Effects of Okadaic Acid and Sodium Orthovanadate on Crocidolite-Induced
Events. Activation of PPases has been implicated in dephosphorylation of a number of

protein kinases, including receptor kinases and protein kinases associated with cell
survival (43-46). However, the identity and relative activity of PPases that inactivate
EGFR and its downstream signaling (Akt and ERKl/2) are not well established. Hence,
we investigated whether PTPases or PSPases played any role in the crocidolite-induced
EGFR, Akt and ERK.1/2 dephosphorylation. Fig. 5-3A shows that 200 nM OA treatments
not only significantly inhibited the observed dephosphorylation of EGFR, Akt and
ERKl/2, but also blocked crocidolite-induced Akt degradation. In contrast to OA, VA
treatment was able to block only EGFR and ERK.1/2 dephosphorylation with no apparent
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Fig. 5-2. Effects of Okadaic Acid and Sodium Orthovanadate on CrocidoliteInduced Serine and Tyrosine Dephosphorylation. Serum-deprived A549 cells were
2
incubated with medium (Control) or treated with 6 µg/cm crocidolite (CRO) for 24 h.
Alternatively, cells were pretreated with 200 nM okadaic acid or 50 µM Na 3V0 4 for 1 h
(Control), followed by incubation with 6 µg/cm 2 crocidolite for 24 h (ONCRO and
VNCRO, respectively). Cellular lysates were subjected to Western blotting analysis, as
described under Materials and Methods. Phosphorylation of the total cellular tyrosine (A)
and serine (B) levels were determined using phospho-specific antibodies. Data presented
is representative of three separate experiments.
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Fig. 5-3. Effects of Okadaic Acid and Sodium Orthovanadate on CrocidoliteInduced Events. Serum-deprived A549 cells were incubated with medium (Control) or
2
treated with 6 µg/cm crocidolite (CRO) for 24 h. Alternatively, cells were pretreated
with 200 nM okadaic acid or 50 µM Na 3 V0 4 for l h (Control), followed by incubation
2
with 6 µg/cm crocidolite for 24 h (OA/CRO and VA/CRO, respectively). Cellular
lysates were subjected to Western blotting analysis, as described under Materials and
Methods. Phosphorylation of EGFR, Akt and ER.Kl/2 was determined using phosphoantibodies specific to activated EGFR, Akt and ER.Kl/2. EGFR, Akt and ER.Kl/2 protein
contents were analyzed with antibodies to EGFR, Akt and ER.Kl/2. Activation of
caspase-3 and -9 was determined with anti-caspase-3 or -9 antibodies. PARP cleavage
analysis was performed with anti-PARP antibody. Data presented is representative of
three separate experiments.
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inhibition of Akt dephosphorylation or degradation. The protective effects of OA and
VA were maximal at 200 nM and 50 µM, respectively, and higher concentrations of both
appeared to be toxic to A549 cells (data not shown).
Okadaic acid, as well as another serine/threonine phosphatase inhibitor calyculin
A, have been shown to inhibit apoptosis (24-26, 47). There are also some reports
emphasizing an important role of PTPase in the regulation of programmed cell death (33,
48). Hence, we investigated the effects of PSPase and PTPase inhibitors on caspase-3
activation and subsequent poly(ADP-ribose) polymerase (P ARP) cleavage (Fig. 5-3B).
Okadaic acid treatment prevented crocidolite-induced apoptosis while VA had little
effect.

DISCUSSION

We have previously reported that exposure ofrelevant human lung and pleural
target cells to asbestos fibers resulted in dephosphorylation and subsequent inactivation
of EGFR (see Chapter 3). Also, we observed that iron-dependent p38 MAPK activation
played a central role in crocidolite-induced apoptosis of human lung epithelial cells via
inhibition of ERKl/2 and Akt survival pathways and concurrent activation of caspase-3
and -9 (see Chapter 3). Results presented here strongly suggest that crocidolite-induced
p38 MAPK-dependent activation of serine/threonine phosphatases directs the cells to
apoptosis. Most importantly, it appears that the fibers must be internalized for the PPases
to be activated, and that the iron associated with fibers was directly or indirectly
responsible for some of this effect.
It is apparent that cells contain simultaneous survival and apoptotic pathways that
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are in part regulated by protein phosphorylation and dephosphorylation. Inhibition of
both protein kinases and phosphatases activity has been shown to prevent apoptosis in a
variety of cell lines (33, 49, 50). There are contradictory reports in the literature regarding
the effects of VA and OA on cells. Both have been shown to inhibit apoptosis (24-26, 3136) or potentiate growth inhibition and apoptosis (22, 23, 34, 37) in a number of cell
lines. It is apparent that the balance between protein phosphorylation pathways regulates
signal transduction events that control a variety of cellular processes ranging from cell
growth and differentiation to apoptosis. Any disturbance of this finely tuned mechanism
may direct the cells to either survival or death. Thus, it appears that the ultimate effects of
VA and OA may be opposite depending on the dominance of either the survival or
apoptotic pathway in a particular cell iine (51 ).
Cytochalasins, the endocytosis inhibitors, blocked asbestos-induced injury to
mesothelial and lung epithelial cells (52). It has also been observed that iron mobilized
from asbestos fibers was responsible for DNA oxidation (53) and mitochondrial
dysfunction (54-56). Additionally, iron mobilized from fibers inside the A549 cells was
shown to initiate crocidolite-induced activation of the apoptotic pathway (see Chapter 3).
Consistent with that, our results presented here showed that decreasing fiber uptake or
removal of bioavailable iron with DF prevented the observed cellular protein
dephosphorylation.
We have recently demonstrated that p38 MAPK played a central role in
crocidolite-induced apoptosis in A549 cells (see Chapter 3). Stimuli other than asbestos,
i.e. nitric oxide (57), arsenite (58), phorbol esters (59), have also been shown to induce
apoptosis in a p38 MAPK-dependent manner. Our results reported herein suggest that the
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upstream activation of p38 MAPK is required for an increased activity of PPases. The
precise mechanism by which p38 MAPK may lead to PPase activation is unclear.
Phosphorylation of the PP2A regulatory subunit has been shown to promote its in vitro
activity (60). It has been suggested that PPases may be direct targets for p38 MAPKmediated phosphorylation . Recent studies showed that PP2A could be activated by p38
MAPK in NIH 3T3 cells (61) and neutrophils (25).
Independent studies have provided strong evidence that asbestos triggers
apoptosis in both rodent (49, 52, 62-64) and human (52, 54-56) cells. It appears that
asbestos-induced apoptosis in lung and pleural target cells may account for the
pathogenic effects of the fibers. However, in contrast to rodent cells, the signaling
cascades involved in asbestos-induced apoptosis in human cells have not yet been
identified . Kamp and coworkers (54-56) have established that asbestos induces apoptosis
in human lung epithelial cells. It was proposed that apoptosis resulted from mitochondri al
dysfunction and was, in part, due to iron-derived ROS. Nevertheless , the signaling
cascades involved in asbestos-induced apoptosis in human cells have not been thoroughly
explored. We have previously observed that exposure to crocidolite resulted in a doseand time-dependent activation of the pro-apoptotic p38 MAPK, and subsequently
initiation of apoptosis in human lung epithelial cells (see Chapter 3). The characteristic
features of apoptosis provided by our studies included a dose- and time-dependent
activation of caspase-3, -9, and subsequent cleavage of PARP. Our results presented here
showed that OA, a potent inhibitor of PSPase PPl and PP2A at the concentrations used,
was able to prevent not only inactivation of EGFR and survival pathways (ERKl/2 and
Akt), but also activation of caspases and cleavage of P ARP . We have previously
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observed that crocidolite treatment resulted in pro-survival Akt dephosphorylation
and subsequent degradation (see Chapter 3). Akt has been shown to be degraded during
apoptosis through a caspase-dependent mechanism (65). Consistent with inhibition of
caspase activity by OA, this treatment was also able to prevent crocidolite-induced Akt
degradation. Our results suggest that PSPases regulate not only phosphorylation of the
serine/threonine residues, but also of tyrosine residues. This was supported by the
observation that treatment of cells with OA, but not with VA, blocked crocidoliteinduced global cellular serine/threonine as well as tyrosine dephosphorylation. Con siste nt
with that, OA treatment also prevented crocidolite-induced dephosphorylation of the
tyrosine residue of EGFR, as recently observed by others (50). It is ambiguous thou gh
how PSPases regulate, directly or indirectly, the dephosphorylation of tyrosine residues .
PP2A, a member of the serine/threonine phosphatase family, is known to display a low
basal phosphotyrosine phosphatase activity (66-69) . Most importantly , Jackson et al. (70)
showed that PP2A was able to regulate the PTPase activity in Lewis lung carcinoma
tumor variants. It appears that PP2A could link serine/threonine and tyrosine sign aling
pathways by regulating PTPases . VA treatment was able to block crocidolite-induced
EGFR and ERK dephosphorylation, but, in contrast to OA, was not able to inhibit Akt
dephosphorylation and degradation, nor did it prevent apoptosis. Interestingly, VA
prevented dephosphorylation of ERK 1/2 on both residues, i.e. threonine 202 and tyrosine
204, which could have been due to inhibition of a DSPase that functioned as a MAPK
phosphatase (71 ). Taken together, it appears that PS Pases, PP 1 and PP2A in particular,
play a central role in crocidolite-induced apoptosis in A549 cells. Even though OA is a
potent inhibitor of both PPl and PP2A, one should be aware that some of the less
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abundant PPases (PP4, PPS, and PP6) are inhibited by these compounds in the same
nanomolar concentration range as PP 1 and PP2A are inhibited (72). Since it is believed
that oxidation of critical cysteine residues within PPases catalytic sites leads to their
inactivation rather than activation, our findings may seem a little bit controversial.
However, it appears that oxidative stress-sensitive p38 MAPK activation (73) may link
asbestos-derived ROS and activation of PPases.
Stimuli other than asbestos have also been shown to induce apoptosis in a
PSPase-dependent manner (74, 75). The precise mechanism by which PSPases lead to
apoptosis is unclear. It has been proposed that phosphorylation and dephosphorylation are
crucial in caspase signaling pathways of apoptosis (72). Many signals activate caspase-9 ,
an initiator protease that activates caspase-3 and downstream caspases to initiate cellular
destruction. Cardone et al. (76) reported that Akt induced phosphorylation of procaspase9. This reversible phosphorylation, which led to procaspase-9 inactivation, appeared to
promote cell survival. Moreover, cytochrome c-induced activation of caspases-9 and -3
required PSPase activity in chronic lymphocytic leukemia cells (77). It was suggested
that the PP2A-induced dephosphorylation of proapoptotic Bcl-2 family members, such as
Bad, was responsible for the observed cell death . Additionally, Allan et al. (78) observed
that ERK MAPK inhibited caspase-9 through phosphorylation at threonine 125. Finally,
activated phosphatases have been shown to regulate the alternative splicing of specific
apoptotic factors, i.e. caspase 9 and Bcl-x (75).
In conclusion, our results indicate that the initial event that triggers apoptosis by
crocidolite in human lung epithelial cells is the p38 MAPK-dependent increase in the
activity of PSPases followed by dephosphorylation ofEGFR and EGFR-associated

140
survival pathways (ERK.1/2 and A.kt) and concomitant activation of caspases. We
speculate that asbestos-induced intracellular imbalance between protein phosphorylation
and dephosphorylation is a critical determinant of both cell survival and death. Despite
significant research advances, the exact mechanism of asbestos-induced carcinogenicity
is not well understood. Increased understanding of the signaling pathways that govern the
ability of cells to survive or undergo apoptosis is of critical importance to identify
predictive factors controlling development of malignant tumors in humans.
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CHAPTER6
SUMMARY

Signaling pathways initiated at the cell surface or from within the cell regulate
transactivation of transcription factors and gene expression that are related to a number of
critical cellular outcomes ranging from proliferation to apoptosis. While several groups
have independently established that asbestos induces apoptosis in the lung cells, the
components of the regulatory network controlling apoptosis, the mechanisms of action
and patterns of interaction of these factors remain elusive. Since some differences were
reported in the way rodent and human cells responded to asbestos fibers, the goal of this
research was to examine and compare the asbestos-induced signaling events in relevant
human lung and pleural target cells, and to determine if iron associated with fibers, as
well as the process of fiber endocytosis, played any role in these events. A significant
finding of this dissertation was that treatment of human lung and pleural cells, i.e.
epithelial (A549 and SAEC) and mesothelial (METSA) cells with asbestos fibers resulted
in dephosphorylation and subsequent inactivation of the ErbB family of receptor tyrosine
kinases. The results presented here support other studies in the literature showing
differences between rodent and human tissue in terms of resistance to genotoxicity and/or
cytotoxicity by asbestos. Another significant finding of this dissertation was that p38
MAPK, through a serine/threonine phosphatase-mediated mechanism, regulates asbestosinduced apoptosis in A549 cells. Of particular importance was that iron mobilized from
fibers inside the cells initiates the crocidolite-induced signaling events preventing
survival, but activating apoptotic pathways. The findings of this dissertation are
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summarized in more details in the following sections.
Treatment of A549, MET5A, and SAEC cells with asbestos caused a significant
reduction of EGFR tyrosine phosphorylation . Our results strongly suggest that the
responses observed in A549 cells were representative of transformed and normal human
cells. We have identified a potentially important mechanism by which relevant human
lung and pleural target cells respond to asbestos fibers. Treatment with crocidolite for 24
h also diminished the phosphorylation levels of HER2. In addition, exposure of A549
cells to crocidolite for 3 to 24 h resulted in no apparent degradation of the EGFR. Most
importantly, inhibition of fiber endocytosis and removal of iron from asbestos by
desferrioxamine B or phytic acid prevented asbestos-induced decreases in EGFR
phosphorylation. We aiso observed that the amount of EGFR dephosphorylation in A549
cells by two types of asbestos, crocidolite and amosite, was significantly greater than that
by the third type , chrysotile, either short or intermediate length fibers . The effects of
crocidolite, amosite and chrysotile on the EGFR phosphorylation state appeared to be
related to the amount of iron mobilized from these fibers. Thus, there appeared to be a
correlation between iron mobilization from asbestos and the degree of EGFR
dephosphorylation. These results strongly suggest that iron plays an important role in
asbestos-induced inactivation of EGFR.
Several independent research groups have provided evidence for the involvement
of some signaling cascades in apoptosis of rodent cells following asbestos exposure .
However, the effects of asbestos on the control and coordination of the signal
transduction pathways in human lung cells have not been investigated. We observed that
exposure of A549 and SAEC cells to crocidolite led to inactivation of the main EGFR

153
signaling pathways, including Akt and ERK 1/2 pathways. Crocidolite also initiated
apoptosis via pathways involving activation of p38 MAPK, caspase -3 and -9, and
cleavage P ARP. Prevention of these effects with an iron chelator or endocytosis
inhibitors strongly suggests that iron mobilized from fibers inside the cells initiates the
observed events. Inhibition of p38 MAPK with SB203580 prevented inactivation of
EGFR, inactivation of EGFR-associated survival pathways, and initiation of apoptosis.
Taken together, it appears that iron-dependent p38 MAPK activation plays a central role
in crocidolite-induced apoptosis of human lung epithelial cells via inhibition of ERK l/ 2
and Akt survival pathways and concurrent activation of caspase-3 and -9. Our results
reveal not only important species differences but also the complexity and diversity of
regulatory mechanisms in asbestos-induced apoptosis. We speculate that apoptosis may
be an important response of relevant human lung target cells and that asbestos
pathogenesis may result from altered apoptotic mechanisms .
Phosphorylation and dephosphorylation of proteins mediate signal transduction
events that control a multitude of cellular processes including cell survival and death .
Recent studies strongly suggest that PTPases as well as PSPases are essential components
critically involved in the control of apoptosis . We therefore investigated the role of
PPases in asbestos-induced apoptosis in A549 cells, using OA and VA, specific inhibitors
of PSPases and PTPases, respectively. Treatment with OA, an inhibitor of PP2A and PP 1
at the concentrations used, but not with VA, protected the cells from asbestos-induced
apoptosis. Importantly, inhibition of p38 MAPK with SB203580, selective decreases in
fiber uptake and removal of the redox active iron from the fibers resulted in significant
attenuation of asbestos -induced dephosphorylation of cellular proteins. Our results
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demonstrate that p38 MAPK, through a serine/threonine phosphatase-mediated
mechanism, regulates asbestos-induced apoptosis in human lung epithelial cells . We
speculate that the intracellular imbalance between protein phosphorylation and
dephosphorylation caused by asbestos is a critical determinant of both cell survival and
death.
Taken together, we propose a model of crocidolite-induced injury in human lung
epithelial cells involving p38 MAPK control of cell survival/apoptosis (Fig. 6-1). The
signaling events appear to be initiated by iron mobilized from crocidolite fibers inside the
cells . Additionally, p38 MAPK appears to control the molecular survival/death switch
that directs the cells away from survival/proliferation to apoptosis. This involves p38
MAPK-mediated activation of protein phosphatases and subsequently dephosphorylation
of EGFR and EGFR-associated survival pathways (Akt and ERKl/2) as well as
activation of apoptotic pathways (casapase-3, -9, P ARP). Importantly , inhibition of p38
MAPK with SB203580, blockage of PSPases with okadaic acid , decreasing fiber uptake
(cytochalasins) and removal ofbioavailable iron with iron chelator desferrioxamine
prevented the observed cellular events and apoptosis. Increased understanding of the
signaling pathways that govern the ability of cells to survive or undergo apoptosis is of
critical importance to identify predictive factors controlling development of malignant
tumors in humans.
A human lung epithelial cell line, A549, with characteristics of alveolar epithelial
type II cells, was used for the majority of these studies. A549 cells are one of the three
most common cultured human lung epithelial cell lines being used as a tissue culture
model of lung epithelial cells in research . The epithelial type II cells are chosen for these
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Fig. 6-1. Model of Crocidolite-Induced p38 MAPK-Mediated Apoptosis in
Human Lung Epithelial Cells.

studies because not only did they appear at crossroads of inflammation, fibrogenesis and
carcinogenesis, but also this type of cells is most likely to come into contact with external
agents, such as particles or asbestos fibers. This cell line was also selected because of its
unlimited proliferation capacity and reproducibility, which is hard to achieve with
primary cells. Since A549 cells were originally obtained from an alveolar carcinoma,
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there was concern that they may not be a faithful representation of normal cells.
Importantly, in some experiments presented here, A549 cells responded in the same way
to crocidolite as normal human small airway epithelial cells (SAEC). Nevertheless, some
of the studies that we have done with only A549 cells should also be carried out in the
primary human lung cells in an attempt to reproduce these results, e.g. p38 MAPK, PPase
and apoptotic pathways activation .
A comparative examination of human and rodent cells showed that patterns of
asbestos-induced signaling events were different. Several explanations for these
dissimilar responses are possible. First of all, species-specific effects may be due to
unusual resistance to cytotoxicity of asbestos by one of the cell lines . Another possibilit y
might be unique patterns and efficiency of DNA repair and/or protective responses to
oxidative stress in different cell types. Although direct comparison of human and rodent
cells are not fully justified, further work needs to be done to determine and understand
the differences between rodent and human tissue in terms of resistance to cytotoxicity by
asbestos.
The concept of redox regulation is emerging as an understanding of the novel
mechanisms in the pathogenesis of several disorders, including viral infections,
immunodeficiency, malignant transformation, and degenerative diseases . Generation of
ROS by iron-catalyzed Haber-Weiss reactions or by cellular response to this cytotoxic
agent may be in excess compared with the levels of thiol buffer, which leads to activation
of the stress kinase cascade and activation of apoptotic effector molecules. Many studies
have shown that ROS lead to activation of p38 MAPK. Several mechanisms have been
proposed for its activation including ROS-dependent dissociation of a molecule that
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maintains the pathway in an inactive state. While strong evidence exists that ROS and
changes in the redox potential of the cells can affect the activation of p38 MAPK, further
studies are required to determine direct targets in this pathway. It is of great importance
to identify new oxidant-sensitive players that are upstream of the p38 MAPK. Also,
further work will be required to understand if and/or how p38 MAPK activation differs
with cell type and between species. As the p38 MAP kinase is involved in the regulation
of transcription, it will be also important to better understand how p38 MAPK activation
regulates gene expression that may be linked sequentially to the development of early cell
injury (apoptosis) and to subsequent compensatory proliferation . Knowledge of the
signaling pathways and physiological responses to cytotoxic agents is essential to
understanding the mechanism of asbestos-related pulmonary toxicity.
Today, the importance of the reversible phosphorylation of proteins in the control
of apoptosis as well as the link between the phosphatases (PP2/PP2A) and apoptosis
fields is clearly established . Our results reported herein suggest that asbestos stimulates
PPases and that the upstream activation of p38 MAPK is required for the observed
increases in PPase activity. The precise mechanism by which p38 MAPK may lead to
PPase activation is unclear. It has been suggested that PPases may be direct targets for
p38 MAPK-mediated phosphorylation. Nevertheless, additional work needs to be done to
determine the exact mechanism by which p38 MAPK , directly or indirectly, activates
PPases in A549 cells.
PSPases appear to have a positive regulatory role in apoptosis by activating proapoptotic and inhibiting anti-apoptotic proteins by dephosphorylation. Even though
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several players regulated by PPases have been determined, further work is required to
identify the specific targets of asbestos-induced PPase-mediated apoptosis.
It has been proposed that apoptosis may represent an important mechanism of

eliminating cells that have asbestos-induced DNA alterations during the process of
carcinogenesis. Even though apoptosis is responsible for normal tissue homeostasis and
elimination of defective or potentially dangerous cells, it has also been observed that
excessive death of cells leads to persistent inflammation. Defects in the control of
apoptotic pathways may contribute to a variety of diseases including autoimmune and
neurodegenerative conditions and AIDS. In addition, some reports suggest that a primary
increase in apoptosis can stimulate compensatory proliferation. Increased cell
proliferation without a compensatory increase in apoptosis may be associated with tumor
promotion and progression. Our understanding of the complex processes of asbestosinduced apoptosis has advanced over the past decade yet many unanswered questions
remain . While there is considerable information regarding asbestos-induced apoptotic
signaling pathways that involve mitochondria, much less is known about pathways that
involve cell surface receptors, stress-activated protein kinases and most importantly
protein phosphatases. A deeper understanding of the physiological importance of
numerous molecules involved in apoptotic signaling pathways requires further
investigation. In addition, much remains to be learnt about how asbestos-induced DNA
damage initiates and regulates the execution of programmed cell death.
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